WO2002009662A2 - Agent for dyeing keratin containing fibers - Google Patents

Agent for dyeing keratin containing fibers Download PDF

Info

Publication number
WO2002009662A2
WO2002009662A2 PCT/EP2001/008656 EP0108656W WO0209662A2 WO 2002009662 A2 WO2002009662 A2 WO 2002009662A2 EP 0108656 W EP0108656 W EP 0108656W WO 0209662 A2 WO0209662 A2 WO 0209662A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
amino
dimethyl
amine
aminopyrazol
Prior art date
Application number
PCT/EP2001/008656
Other languages
German (de)
French (fr)
Other versions
WO2002009662A3 (en
Inventor
David Rose
Frank Naumann
Bernd Meinigke
Horst Höffkes
Original Assignee
Henkel Kommanditgesellschaft Auf Aktien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kommanditgesellschaft Auf Aktien filed Critical Henkel Kommanditgesellschaft Auf Aktien
Priority to EP01980217A priority Critical patent/EP1304995A2/en
Priority to AU2002212116A priority patent/AU2002212116A1/en
Publication of WO2002009662A2 publication Critical patent/WO2002009662A2/en
Publication of WO2002009662A3 publication Critical patent/WO2002009662A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom

Definitions

  • the invention relates to a new agent for dyeing keratin-containing fibers, which contains oxidation dye precursors, and a method for dyeing keratin fibers.
  • oxidation coloring agents play a preferred role because of their intense colors and good fastness properties.
  • colorants contain oxidation dye precursors, so-called developer components and coupler components.
  • developer components form the actual dyes under the influence of oxidizing agents or atmospheric oxygen with one another or under coupling with one or more coupler components.
  • Good oxidation dye precursors must first of all meet the following requirements: they must develop the desired color shades with sufficient intensity and authenticity in the oxidative coupling. They must also have a good ability to draw onto the fiber, with no noticeable differences between stressed and freshly regrown hair, especially with human hair (leveling ability). They should be resistant to light, heat and the influence of chemical reducing agents, e.g. B. against perm fluids. After all, if they are used as a hair dye, they should not stain the scalp too much, and above all they should be harmless from a toxicological and dermatological point of view.
  • M-Phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones, m-aminophenols and substituted pyridine derivatives are generally used as coupler components.
  • Suitable coupler substances are, in particular, ⁇ -naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethyl ether, m-phenylenediamine, 2,4 -Diaminophenoxyethanol, 2-amino-4- (2'-hydroxyethylamino) anisole, 1-phenyl-3-methyl-pyrazolon-5, 2,4-dichloro-3-aminophenol, 1, 3-bis- (2nd ', 4'-diaminophenoxy) propane, 2-chlororesorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 3-amino-6-methoxy-2- methylamino-pyridine and 3,5-diamino-2,6-dimethoxypyridine.
  • the present invention therefore relates to compositions for dyeing keratin-containing fibers containing oxidation dye precursors, characterized in that at least one compound of the general formula I is present as developer components
  • R1 and R2 can be the same or different and represent hydrogen, C 1-4 alkyl or C 1-4 -
  • R3 stands for a group with the formula II, (II),
  • R4 represents a piperazinyl radical or a group -NR7 (CH 2 ) n -NR7, in which R7 is hydrogen or C 1-4 -alkyl and n can be an integer from 1 to 4, R5 and R6 are identical or different can be hydrogen, C 1-4 alkyl or C 1-4 hydroxyalkyl,
  • R9 is hydrogen, C 1-4 -alkyl or C 1- -hydroxyalkyl
  • Y represents a direct bond or a straight-chain or branched C ⁇ -5 - alkylene group
  • A stands for a saturated or unsaturated, optionally containing one or more heteroatoms 5-, 6- or 7-ring, a group -CO-NH 2 , a -C -4 - alkoxy group or a C 1-4 -dialkylamino group, where A with can be linked to any carbon atom of the alkylene group Y.
  • Fibers, wool, feathers and in particular human hair are to be understood as fibers containing keratin.
  • compositions according to the invention are primarily suitable for dyeing keratin fibers, there is in principle nothing to prevent them from being used in other areas, in particular in color photography.
  • physiologically tolerable salts can also be prepared in a manner known per se.
  • examples of such salts are the hydrochlorides, the hydrobromides, the sulfates, the phosphates, the acetates, the propionates, the citrates and the lactates.
  • R3 stands for a group of the formula II.
  • those compounds have proven to be particularly suitable in which R1 and R6 and R2 and R5 are each the same.
  • Examples of preferred compounds which fall under this embodiment are (1,3-dimethyl-4-aminopyrazol-5-yl) - (2 - ((1,3-dimethyl-4-aminopyrazol-5-yl) amino) ethyl) amine and 1,4-bis (1,3-dimethyl-4-aminopyrazol-5-yl) piperazine and their physiologically tolerable salts.
  • compounds of the formula I are preferred in which the group A represents one of the groups piperidyl-, morpholin-4-yl-, imidazolyl-, cyclopentyl-, piperazinyl-, pyrazolyl- or phenyl-.
  • the compounds of the formula I in which Y represents an ethylene or a propylene group are also preferred.
  • Examples of such preferred compounds of the formula I are (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2-piperidylethyl) amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2- (morpholin-4'-yl) ethyl) amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (3- (morpholin-4'-yl) propyl) amine, 1 , 3-dimethyl-4-amino-5-pyrazolylpyrazol, (1, 3-dimethyl-4-aminopyrazole-5-yl) - (3-imidazolylpropyl) - amine, N- (4 - ((1, 3 '-Dimethyl-4'-aminopyrazol-5'-yl) -amino) pentyl) -N, N-diethyl-amine, (1, 3-dimethyl-4-aminopyrazol-5-y
  • the agents according to the invention are particularly well suited as so-called oxidation coloring agents.
  • the compound of formula I used according to the invention acts as a developer component. If desired, further developer components as well as one or more coupler components can be included.
  • Primary aromatic amines with a further free or substituted hydroxy or amino group in the para or ortho position, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine and. are usually further developer components its derivatives used.
  • Very particularly preferred further developer components are p-phenylenediamine, p-toluenediamine, N, N-bis (2'-hydroxyethyl) -p-phenylenediamine, 2,4,5,6-tetraminopyrimidine, 1- (2'-hydroxyethyl) - 2,5-diaminobenzene, 3-methyl-4-aminophenol, o-aminophenol, 2-aminomethyl and 2-hydroxymethyl-4-aminophenol.
  • the agent according to the invention contains at least one coupler component.
  • M-Phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are generally used as coupler components.
  • Coupler components preferred according to the invention are m-aminophenol and its derivatives such as 5-amino-2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 2,6-dimethyl-3-ami- nophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5- (2'-hydroxyethyl) amino -2-methylphenol, 3- (diethylamino) phenol, N-cyclopentyl-3-aminophenol, 1, 3-dihydroxy-5- (methylamino) benzene, 3- (ethylamino) -4-methylphenol and 2,4-dichloro -3-aminophenol,
  • o-aminophenol and its derivatives o-aminophenol and its derivatives
  • m-diaminobenzene and its derivatives such as 2,4-diaminophenoxyethanol
  • Di- or trihydroxybenzene derivatives such as resorcinol, resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1, 2,4-trihydroxybenzene,
  • Pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyhdin, 2-
  • Amino-5-chloro-3-hydroxypyridine 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6- Diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine,
  • Naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1, 5-dihydroxynaphthalene, 1, 6-dihydroxy-naphthalene, 1, 7-dihydroxynaphthalene, 1, 8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene,
  • Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-amino-benzomorpholine,
  • Quinoxaline derivatives such as 6-methyl-1, 2,3,4-tetrahydroquinoxaline, pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one, Indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole,
  • - Pyrimidine derivatives such as 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4-methylpyrimidine , 2-amino-4-hydroxy-6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine, or
  • Methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1 - (2'-hydroxyethyl) amino-3,4-methylenedioxybenzene.
  • coupler components are 1-naphthol, 1, 5-, 2,7- and 1, 7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4- Chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
  • the agents according to the invention preferably contain the compounds of formula I and any coupler components present in an amount of 0.005 to 20% by weight, preferably 0.1 to 5% by weight, each based on the total agent.
  • the individual components are preferably used in approximately molar amounts to one another. If molar use has also proven to be expedient, a certain excess of individual oxidation dye precursors is not disadvantageous, so that developer components and coupler components in a molar ratio of 1: 0.5 to 1: 3, in particular 1: 1 to 1: 2 , can be included.
  • the agents according to the invention contain, in addition to the compounds contained according to the invention, customary direct dyes, e.g. B. from the group of nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • customary direct dyes e.g. B. from the group of nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • Preferred direct dyes are those with the international names or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, Basic Yellow 57, Disperse Orange 3, HC Red 3, HC Red BN, Basic Red 76, HC Blue 2, HC Blue 12, Disperse Blue 3, Basic Blue 99, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Disperse Black 9, Basic Brown 16 and Basic Brown 17 known compounds as well as 1,4-bis- (2'- hydroxyethyl) - amino-2-nitrobenzene, 3-nitro-4- (2'-hydroxyethyl) aminophenol, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1, 2,3,4-tetrahydroquinoxaline, 2- Hydroxy-1, 4-naphthoquinone, hydroxyethyl-2-nitro-toluidine, picraminic acid, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6
  • preparations according to the invention can also contain naturally occurring dyes such as, for example, henna red, henna neutral, henna black, chamomile flowers, sandalwood, black tea, rotten tree bark, sage, blue wood, madder root, catechu, sedre and alkanna root.
  • naturally occurring dyes such as, for example, henna red, henna neutral, henna black, chamomile flowers, sandalwood, black tea, rotten tree bark, sage, blue wood, madder root, catechu, sedre and alkanna root.
  • oxidation dye precursors or the optional direct dyes each represent uniform compounds. Rather, in the agents according to the invention, due to the manufacturing process for the individual dyes, further components may be contained in minor amounts, provided that these do not adversely affect the coloring result or for other reasons, e.g. B. toxicological, must be excluded.
  • Further dye components contained in the agents according to the invention can also be indoles and indolines, as well as their physiologically tolerable salts.
  • Preferred examples are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, 6 -Hydroxyindole, 6-aminoindole and 4-aminoindole.
  • the agents according to the invention produce intensive colorations even at physiologically compatible temperatures of below 45 ° C. They are therefore particularly suitable for dyeing human hair.
  • the agents can usually be incorporated into a water-containing cosmetic carrier.
  • Suitable water-containing cosmetic carriers are e.g. B. creams, emulsions, gels or surfactant-containing foaming solutions such.
  • B. shampoos or other preparations that are suitable for use on the keratin fibers.
  • the agents according to the invention can contain all active ingredients, additives and auxiliaries known in such preparations.
  • the agents contain at least one surfactant, and in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable. In many cases, however, it has proven advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • Suitable anionic surfactants in preparations according to the invention are all anionic surface-active substances suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 10 to 22 carbon atoms.
  • anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 10 to 22 carbon atoms.
  • glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups can be contained in the molecule.
  • suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts with 2 or 3 carbon atoms in the alkanol group,
  • Ether carboxylic acids of the formula RO- (CH 2 -CH 2 O) x -CH 2 -COOH, in which R is a linear alkyl group with 10 to 22 C atoms and x 0 or 1 to 16, acyl sarcosides with 10 to 18 C atoms in the acyl group, Acyltauhde with 10 to 18 C atoms in the acyl group, Acyl isethionates with 10 to 18 C atoms in the acyl group,
  • Sulfosuccinic acid mono- and dialkyl esters with 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid mono-alkyl polyoxyethyl esters with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates with 12 to 18 carbon atoms, linear alpha-olefin sulfonates with 12 to 18 carbon atoms, alpha-sulfofatty acid methyl ester of fatty acids with 12 to 18 carbon atoms, alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -SO 3 H, in which R is a preferably linear alkyl group with 10 to 18 C atoms and x 0 or 1 to 12, mixtures of surface-active hydroxysulfonates according to DE-A-37 25 030, sulfated hydroxy
  • Esters of tartaric acid and citric acid with alcohols the addition products of about 2 to 15 molecules of ethylene oxide and / or propylene oxide to fatty alcohols with 8 to 22 carbon atoms.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids with 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, and in particular salts of saturated and in particular unsaturated C 8 -C 22 carboxylic acids, such as oleic acid, stearic acid, isostearic acid and palmitic acid.
  • Zwitterionic surfactants are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO (_) - or -S ⁇ 3 H group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example coconut alkyl dimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example coconut acylaminopropyl dimethylammonium glycinate, and 2 -Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known
  • Ampholytic surfactants are surface-active compounds which, in addition to a C 8-18 alkyl or acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and are capable of forming internal salts are.
  • ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkyl sarcosine, 2-alkylaminopropionic acid and alkylaminoacetic acid each about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-Kokosalkylaminopropio- nat, cocoacylaminoethyl aminopropionate and C 12- ⁇ 8 acyl sarcosine.
  • Nonionic surfactants contain z as a hydrophilic group.
  • Such connections are, for example
  • Examples of the cationic surfactants which can be used in the hair treatment compositions according to the invention are, in particular, quaternary ammonium compounds.
  • Ammonium halides such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylam onium chlorides, e.g. B. cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride.
  • the quaternized protein hydrolysates are further cationic surfactants which can be used according to the invention.
  • cationic silicone oils such as, for example, the commercially available products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone, which is also referred to as amodimethicone) will), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt; diquaternary polydimethylsiloxanes, Quaternium-80).
  • alkylamidoamines especially fatty acid amidoamines such as the stearylamidopropyldimethylamine available under the name Tego Amid ® S 18, are notable for their good biodegradability. Also very good biodegradability are quaternary Estereducatingen, so-called “esterquats”, dialkoyloxyalkylammoniummethosulfate such as those sold under the trademark Stepantex ® methyl hydroxyalkyl.
  • a suitable cationic surfactant quaternary sugar derivative is the commercial product Glucquat ® 100, according to CTFA nomenclature a "lauryl methyl Gluceth-10 Hydroxypropyl Dimonium Chloride”.
  • the compounds with alkyl groups used as surfactants can each be uniform substances. However, it is generally preferred to start from natural vegetable or animal raw materials in the production of these substances, so that substance mixtures with different alkyl chain lengths depending on the respective raw material are obtained.
  • both products with a "normal” homolog distribution and those with a narrowed homolog distribution can be used.
  • “Normal” homolog distribution is understood to mean mixtures of homologs which are obtained as catalysts from the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates.
  • narrow homolog distributions are obtained if, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with a narrow homolog distribution can be preferred.
  • nonionic polymers such as, for example, vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers and polysiloxanes
  • cationic polymers such as quaternized cellulose ethers, polysiloxanes with quaternary groups, dimethyldioxylammonylammonylammonylammonylammonylammonyl amide Copolymers, dimethylaminoethyl methacrylate quaternized with diethyl sulfate, vinyl pyrrolidone copolymers, vinyl pyrrolidone imidazolinium methochloride copolymers and quaternized polyvinyl alcohol, zwitterionic and amphoteric polymers such as acrylamidopropyl-trimethylammonium chloride / acrylate copolymers and octyl
  • Protein hydrolyzates in particular elastin, collagen, keratin, milk protein, soy protein and wheat protein hydrolyzates, their condensation products with fatty acids and quaternized protein hydrolyzates, perfume oils, dimethyl isosorbide and cyclodextrins,
  • Solubilizers such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerin and diethylene glycol,
  • Anti-dandruff agents such as piroctone olamine and zinc omadine, other substances for adjusting the pH value,
  • Active ingredients such as panthenol, pantothenic acid, allantoin, pyrrolidone carboxylic acids and their salts, plant extracts and vitamins, cholesterol, light stabilizers,
  • Consistency enhancers such as sugar esters, polyol esters or polyol alkyl ethers, fats and waxes such as walrus, beeswax, montan wax, paraffins, fatty alcohols and fatty acid esters, fatty acid alkanolamides,
  • Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates, hydrogen carbonates, guanidines, ureas and primary, secondary and tertiary phosphates, imidazoles, tannins, pyrrole, Opacifiers like latex,
  • Pearlescent agents such as ethylene glycol mono- and distearate
  • Blowing agents such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air as well
  • constituents of the water-containing carrier are used for the preparation of the agents according to the invention in amounts customary for this purpose; z.
  • emulsifiers are used in concentrations of 0.5 to 30% by weight and thickeners in concentrations of 0.1 to 25% by weight of the total agent.
  • Suitable metal salts are e.g. B. formates, carbonates, halides, sulfates, butyrates, valerates, capronates, acetates, lactates, glycolates, tartrates, citrates, gluconates, propionates, phosphates and phosphonates of alkali metals, such as potassium, sodium or lithium, alkaline earth metals, such as Magnesium, calcium, strontium or barium, or of aluminum, manganese, iron, cobalt, copper or zinc, whereby sodium acetate, lithium bromide, calcium bromide, calcium gluconate, zinc chloride, zinc sulfate, magnesium chloride, magnesium sulfate, ammonium carbonate, chloride and acetate are preferred.
  • These salts are preferably present in an amount of 0.03 to 65, in particular 1 to 40, mmol based on 100 g of the total composition
  • Another object of the present invention is a process for dyeing keratin-containing fibers, in particular human hair, in which a colorant according to the invention, containing customary cosmetic ingredients, is applied to the keratin-containing fibers, left on the fiber for some time, usually about 30 minutes, and then rinsed out again or washed out with a shampoo.
  • a colorant according to the invention containing customary cosmetic ingredients
  • the oxidative development of the coloring can take place with atmospheric oxygen.
  • a chemical oxidizing agent is preferably used, especially if, in addition to the coloring, a lightening effect on human hair is desired.
  • Persulfates, chlorites and in particular hydrogen peroxide or its adducts with urea, melamine and sodium borate are suitable as oxidizing agents. It is also possible to carry out the oxidation with the aid of enzymes.
  • the enzymes can be used to transfer atmospheric oxygen to the developer component or to enhance the effect of small amounts of oxidizing agents present.
  • An example of an enzymatic Process represents the procedure to increase the effect of small amounts (eg 1% and less, based on the total agent) of hydrogen peroxide by peroxidases.
  • the preparation of the oxidizing agent is expediently mixed with the preparation from the oxidation dye precursors immediately before hair dyeing.
  • the resulting ready-to-use hair dye preparation should preferably have a pH in the range between 2 and 11, preferably between 5 and 10. It is particularly preferred to use the hair products in a weakly alkaline environment.
  • the application temperatures can range between 15 and 40 ° C.
  • the agent is removed from the hair to be colored by rinsing. Washing with a shampoo is not necessary if a carrier with a high tenside content, e.g. a coloring shampoo was used.
  • Yet another object of the present invention relates to the use of compounds of the formula (I) for dyeing fibers containing keratin.
  • Step 1 (4-nitro-1,3-dimethylpyrazol-5-yl) - (2 - ((4-nitro-1,3-dimethylpyrazol-5-yl) amino) ethyl) -amir
  • 5 g (0.025 mol) of 5-chloro-1, 3-dimethyl-4-nitropyrazole, 1.7 g (0.125 mol) of K 2 CO 3 and 0.1 g of Cu powder in 100 ml of 1-butanol were at 80 ° C.
  • a solution of 0.75 g (0.0125 mol) of 1,2-diaminoethane in 25 ml of 1-butanol was added dropwise. After refluxing for 13 hours, the hot solution was filtered off, after cooling the product was filtered off with suction. Yellow crystals with a melting point of 237 ° C. were obtained
  • the product from stage 1 was hydrogenated in 200 ml of ethanol and 0.1 g of Pd / C at 78 ° C. and 25 atm. After the H 2 uptake had ended, the catalyst was filtered off. The solution was acidified with dilute HCl and evaporated to dryness. There was (4-amino-1, 3-dimethylpyrazol-5-yl) - (2 - ((4-amino-1, 3-dimethylpyrazol-5-yl) amino) ethyl) amine x 4HCI in the form of brown crystals with obtained a melting point of 220 ° C.
  • Stage 1 Stage 1 from preparation example 1 was repeated, using 1.1 g (0.0125 mol) of piperazine instead of 1,2-diaminoethane.
  • Stage 2 analogous to stage 2 from preparation example 1. 1,4-bis- (1,3-dimethyl-4-nitro-pyrazol-5-yl) -piperazine x 4 HCl was obtained in the form of orange crystals with a melting point above 206 ° C obtained (decomposition).
  • Step 1 A mixture of 7 g (0.04 mol) of 5-chloro-1, 3-dimethyl-4-nitropyrazole, 10.3 g (0.08 mol) of 1- (2-aminoethyl) piperidine and 4 g (0.048 mol) NaHCO 3 in 60 ml dimethyl sulfoxide was stirred at 90 ° C for 4 hours. The reaction mixture was poured onto 500 g of ice and the precipitate was filtered off with suction. Yellow crystals with a melting point of 124 ° C. were obtained. Stage 2: 9 g of the product obtained in stage 1 were hydrogenated in 400 ml of ethanol with 0.6 g of Pd / C at room temperature and 1 atm.
  • Step 1 Step 1 from preparation example 3 was repeated, using 10.4 g (0.08 mol) of N- (2-aminoethyl) morpholine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 112-114 ° C. were obtained.
  • Step 2 analogous to step 2 from preparation example 3. It was (4-amino-1, 3-dimethylpyrazol-5-yl) - (2-morpholin-4-yl-ethyl) amine x 3HCI in the form of yellow crystals with obtained a melting point of 105 ° C.
  • Step 1 Step 1 from preparation example 3 was repeated, using 11.5 g (0.08 mol) of N- (3-aminopropyl) morpholine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 87-89 ° C. were obtained.
  • Step 2 analogous to step 2 from preparation example 3. It was (4-amino-1, 3-dimethylpyrazol-5-yl) -3-morpholin-4-yl-propyl) amine x 3HCI in the form of yellow crystals with a Obtained melting point of 104 ° C.
  • Step 1 To a solution of 5 g (0.028 mol) of 5-hydrazino-1, 3-dimethyl-4-nitro-1H-pyrazole and 4.68 g (0.028 mol) of tetramethoxypropane in 80 ml of ethanol were 19. Given 8 ml of 10% HCI. The mixture was boiled under reflux for 2 hours, then 3 g (0.028 mol) of Na 2 CO 3 in 10 ml of H 2 O were added and the solution became dry evaporated. The residue was extracted with ethanol. After concentration, the residue was recrystallized from EtOH. Bright orange crystals with a melting point of 75 ° C. were obtained.
  • Stage 2 analogous to stage 2 from preparation example 3. This gave (1,3-dimethyl-5-pyrazolyl-pyrazo-4-amine x 3HCI in the form of orange crystals and a melting point> 150 ° C. (decomposition).
  • Step 1 Step 1 from preparation example 3 was repeated, using 10.09 g (0.08 mol) of 1- (3-aminopropyl) imidazole instead of 1- (2-aminoethyl) piperidine. A yellow oil was obtained.
  • Step 2 analogous to step 2 from preparation example 3. (4-Amino-1,3-dimethylpyrazol-5-yl) - (3-imidazolylpropyl) amine x 3HCI was obtained in the form of a brown oil.
  • Step 1 Step 1 from preparation example 3 was repeated, using 12.7 g (0.08 mol) of 2-amino-5- (diethylamino) pentane instead of 1- (2-aminoethyl) piperidine. A yellow oil was obtained.
  • Step 2 analogous to step 2 from preparation example 3. (4-Amino - ((1, 3-dimethyl-4-aminopyrazol-5-yl) -amino) pentyl) -diethylamine x 3HCI was obtained in the form of a brown oil.
  • Step 1 Step 1 from preparation example 3 was repeated, using 5.9 g (0.08 mol) of glycinamide instead of 1- (2-aminoethyl) piperidine. Orange crystals with a melting point above 250 ° C. were obtained.
  • Step 2 analogous to step 2 from preparation example 3. 2 - ((4-A ⁇ mino-1, 3-dimethylpyrazol-5-yl) -amino) -acetamide x 2HCI in the form of a beige powder with a melting point of 220 ° C. ( Decomposition).
  • Step 1 Step 1 from preparation example 3 was repeated, using 6.8 g (0.08 mol) of cyclopentylamine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 76-80 ° C. were obtained.
  • Step 2 analogous to step 2 from preparation example 3. 4-Amino-1,3-dimethylpyrazol-5-yl-cyclopentylamine x 2HCI was obtained in the form of beige powder with a melting point of 147 ° C.
  • Step 1 Step 1 from preparation example 3 was repeated, using 10.3 g (0.08 mol) of 1- (2-aminoethyl) piperazine instead of 1 - (2-aminoethyl) piperidine. Yellow crystals with a melting point of 124 ° C. were obtained.
  • Stage 2 analogous to stage 2 from preparation example 3. (1, 3-dimethyl-4-amino-5-yl) - (2-piperazinylethylamine) x 4HCI was obtained in the form of brown crystals with a melting point above 108 ° C. (decomposition) , Production Example 12
  • Step 1 Step 1 from preparation example 3 was repeated, using 8.3 g (0.08 mol) of 3-ethoxypropylamine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 44 ° C. were obtained.
  • Stage 2 analogous to stage 2 from preparation example 3. 4-Amino-1,3-dimethylpyrazol-5-yl) - (3-ethoxypropyl) amine x 3HCI was obtained in the form of orange-colored hygroscopic crystals.
  • Step 1 Step 1 from preparation example 3 was repeated, 9.7 g (0.08 mol) of 2-phenylethylamine being used instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 99-101 ° C. were obtained.
  • Stage 2 analogous to stage 2 from preparation example 3. It became (4-amino-1,3-dimethylpyrazol-5-yl) - (2-phenylethyl) amine x 2HCI in the form of gray-blue crystals with a melting point of 85-90 ° C received.
  • Step 1 7.9 g (0.045 mol) of 5-chloro-1,3-dimethyl-4-nitropyrazole were placed in 60 ml of dimethyl sulfoxide with stirring in a nitrogen atmosphere. A solution of 5 g (0.045 mol) glycinamide hydrochloride, 7.5 g potassium carbonate (0.054 mol) and 20 ml water was added. The mixture was then stirred at 70 ° C. for 22 h. The reaction mixture was cooled and poured onto ice. The yellow / orange precipitate was suction filtered, washed with water, slurried in 50 ml of cold dimethylformamide, suction filtered again and washed with water. The reaction product was dried at 50 ° C in a vacuum and had a melting point above 250 ° C.
  • Step 2 3 g (0.014 mol) of 2 - ((1 ', 3'-dimethyl-4'-nitropyrazol-5'-yl) amino) -acetamide were dissolved in 150 ml of ethanol and 50 ml of water with 0.65 g of a Pd catalyst ( 5% Pd on C) at Room temperature hydrogenated. 20 ml of a 20% HCl solution were then added, the reaction mixture was filtered under nitrogen and evaporated to dryness. 2 - ((1 ', 3'-Dimethyl-4 , -aminopyrazol-5'-yl) amino) -acetamide dihydrochloride was obtained, which decomposed at 220 ° C.
  • Step 1 8.0 g (0.046 mol) of 5-chloro-1, 3-dimethyl-4-nitropyrazole, 3.6 g (0.042 mol) of cyclopentylamine and 4.4 g (0.052 mol) of sodium hydrogen carbonate were in 50 ml of dimethyl sulfoxide for 22 h at 75 to 80 ° C stirred. The reaction mixture was cooled and poured onto ice. The yellow precipitate was filtered off and recrystallized from 500 ml of water at 50 to 60 ° C. The reaction product was dried at 50 ° C in a vacuum and had a melting point of 76 to 80 ° C with decomposition.
  • Step 2 6.1g (0.027 mol) (1,3-dimethyl-4-nitropyrazol-5-yl) cyclopentylamine were dissolved in 75ml ethanol and 25ml water with 0.53g Pd catalyst (5% Pd on C) at 50 ° C and 20bar hydrogenated for 24h in an autoclave. 20 ml of a 20% HCl solution were then added, the reaction mixture was filtered under nitrogen and evaporated to dryness. (1, 3-Dimethyl-4-aminopyrazol-5-yl) cyclopentylamine was obtained, which decomposed at 147 ° C.
  • Cetylstearyl alcohol with approx. 20 EO units (INCI name: Ceteareth-
  • the ingredients were mixed together in order. After the oxidation dye precursors and the inhibitor had been added, concentrated ammonia solution, the pH of the emulsion was adjusted to 10, then the mixture was made up to 100 g with water.
  • the oxidative development of the color was carried out with atmospheric oxygen or 1% hydrogen peroxide solution as the oxidation solution.
  • the emulsion for air oxidation was left as it was, for oxidation with H 2 O 2 , 100 g of the emulsion were mixed with 50 g of hydrogen peroxide solution (1%) and mixed.
  • the resulting application preparation was applied in each case to strands of approximately 5 cm long, standardized, 90% gray, but not specially pretreated human hair and left there at 32 ° C. for 30 minutes. After the dyeing process was completed, the hair was rinsed, washed with a conventional shampoo and then dried. The following developer and coupler components were used for the colorations:
  • Oleic acid (INCI name: Oleic Acid) (Cognis)
  • Lauryl ether sulfate sodium salt (approx. 26.5 to 27.5% active substance content; INCI name: Sodium Laureth Sulfate) (Cognis)
  • Wheat protein hydrolyzate (approx. 40% solids; INCI name: Aqua (Water), Hydrolyzed Wheat Protein, Sodium Benzoate, Phenoxyethanol, Methylparaben, Propylparaben) (Cognis)
  • Lauryl myristyl ether sulfate sodium salt (approx. 68 to 73% active substance content; INCI name: Sodium Myreth Sulfate) (Cognis)
  • Lauryl alcohol-4.5-EO-acetic acid sodium salt (at least 21% active substance content; INCI name: Sodium Laureth-6 carboxylate) (Chem-Y)

Abstract

The invention relates to an agent for dyeing keratin containing fibers which comprises as the developer at least one compound of the general formula (I), wherein R1 and R2 are the same or different and represent hydrogen, C1-4 alkyl or C1-4 hydroxyalkyl, and R3 represents a group of the formula (II), wherein R4 represents a piperazinyl group or a group -NR7(CH2)n-NR7, wherein R7 represents hydrogen or C1-4 alkyl and n is an integer of from 1 to 4, R5 and R6 are the same or different and represent hydrogen, C1-4 alkyl or C1-4 hydroxyalkyl, or else R3 represents a group (III), or a group (IV), wherein R9 represents hydrogen, C1-4 alkyl or C1-4 hydroxyalkyl, Y represents a direct bond or a straight-chain or branched C1-5 alkylene group, and A represents a saturated or unsaturated 5-, 6- or 7-membered ring optionally containing one or more heteroatoms, a group -CO-NH2, a C1-4 alkoxy group or a C1-4 dialkylamino group, wherein A may be linked with any carbon atom of the alkylene group Y.

Description

"Mittel zum Färben von keratinhaltigen Fasern" "Means for dyeing fibers containing keratin"
Die Erfindung betrifft ein neues Mittel zum Färben von keratinhaltigen Fasern, das Oxidati- onsfarbstoffvorprodukte enthält, sowie ein Verfahren zum Färben von Keratinfasern.The invention relates to a new agent for dyeing keratin-containing fibers, which contains oxidation dye precursors, and a method for dyeing keratin fibers.
Für das Färben von Keratinfasern, insbesondere menschlichen Haaren, spielen die sogenannten Oxidationsfärbemittel wegen ihrer intensiven Farben und guten Echtheitseigenschaften eine bevorzugte Rolle. Solche Färbemittel enthalten Oxidationsfarbstoffvorpro- dukte, sogenannte Entwicklerkomponenten und Kupplerkomponenten. Die Entwicklerkomponenten bilden unter dem Einfluß von Oxidationsmitteln oder von Luftsauerstoff untereinander oder unter Kupplung mit einer oder mehreren Kupplerkomponenten die eigentlichen Farbstoffe aus.For the coloring of keratin fibers, especially human hair, the so-called oxidation coloring agents play a preferred role because of their intense colors and good fastness properties. Such colorants contain oxidation dye precursors, so-called developer components and coupler components. The developer components form the actual dyes under the influence of oxidizing agents or atmospheric oxygen with one another or under coupling with one or more coupler components.
Gute Oxidationsfarbstoffvorprodukte müssen in erster Linie folgende Voraussetzungen erfüllen: Sie müssen bei der oxidativen Kupplung die gewünschten Farbnuancen in ausreichender Intensität und Echtheit ausbilden. Sie müssen ferner ein gutes Aufziehvermögen auf die Faser besitzen, wobei insbesondere bei menschlichen Haaren keine merklichen Unterschiede zwischen strapaziertem und frisch nachgewachsenem Haar bestehen dürfen (Egalisiervermögen). Sie sollen beständig sein gegen Licht, Wärme und den Einfluß chemischer Reduktionsmittel, z. B. gegen Dauerwellflüssigkeiten. Schließlich sollen sie - falls als Haarfärbemittel zur Anwendung kommend - die Kopfhaut nicht zu sehr anfärben, und vor allem sollen sie in toxikologischer und dermatologischer Hinsicht unbedenklich sein.Good oxidation dye precursors must first of all meet the following requirements: they must develop the desired color shades with sufficient intensity and authenticity in the oxidative coupling. They must also have a good ability to draw onto the fiber, with no noticeable differences between stressed and freshly regrown hair, especially with human hair (leveling ability). They should be resistant to light, heat and the influence of chemical reducing agents, e.g. B. against perm fluids. After all, if they are used as a hair dye, they should not stain the scalp too much, and above all they should be harmless from a toxicological and dermatological point of view.
Als Entwicklerkomponenten werden üblicherweise primäre aromatische Amine mit einer weiteren, in para- oder ortho-Position befindlichen, freien oder substituierten Hydroxy- oder Aminogruppe, Diaminopyridinderivate sowie 2,4,5,6-Tetraaminopyrimidin und dessen Derivate eingesetzt. Spezielle Vertreter sind beispielsweise p-Phenylendiamin, p-Toluylendiamin, 2,4,5,6-Tetra- aminopyrimidin, p-Aminophenol, N,N-Bis(2'-hydroxyethyl)-p-phenylendiamin, 2-(2',5'-Diami- nophenyl)-ethanol, 2-(2,5-Diaminophenoxy)-ethanol, 4-Amino-3-methylphenol, 2-Aminome- thyl-4-aminophenol, 2-Hydroxy-4,5,6-triaminopyrimidin, 2,4-Dihydroxy-5,6-diaminopyrimidin, 2,5,6-Triamino-4-hydroxypyrimidin und 1 ,3-N,N'-Bis(2'-hydroxyethyl)-N,N'-bis(4'-aminophe- nyl)-diamino-propan-2-ol.Primary aromatic amines with a further free or substituted hydroxyl or amino group in the para or ortho position, diaminopyridine derivatives and 2,4,5,6-tetraaminopyrimidine and its derivatives are usually used as developer components. Specific representatives are, for example, p-phenylenediamine, p-toluenediamine, 2,4,5,6-tetraaminopyrimidine, p-aminophenol, N, N-bis (2'-hydroxyethyl) -p-phenylenediamine, 2- (2 ', 5'-diaminophenyl) ethanol, 2- (2,5-diaminophenoxy) ethanol, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol, 2-hydroxy-4,5,6- triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, 2,5,6-triamino-4-hydroxypyrimidine and 1,3-N, N'-bis (2'-hydroxyethyl) -N, N'-bis ( 4'-aminophenyl) diamino-propan-2-ol.
Als Kupplerkomponenten werden in der Regel m-Phenylendiaminderivate, Naphthole, Re- sorcin und Resorcinderivate, Pyrazolone, m-Aminophenole und substituierte Pyridinderivate verwendet. Als Kupplersubstanzen eignen sich insbesondere α-Naphthol, 1 ,5-, 2,7- und 1 ,7- Dihydroxynaphthalin, 5-Amino-2-methylphenol, m-Aminophenol, Resorcin, Resorcinmono- methylether, m-Phenylendiamin, 2,4-Diaminophenoxyethanol, 2-Amino-4-(2'-hydroxyethyl- amino)-anisol, 1-Phenyl-3-methyl-pyrazolon-5, 2,4-Dichlor-3-aminophenol, 1 ,3-Bis-(2',4'- diaminophenoxy)-propan, 2-Chlorresorcin, 4-Chlorresorcin, 2-Chlor-6-methyl-3-amino- phenol, 2-Methylresorcin, 5-Methylresorcin, 3-Amino-6-methoxy-2-methylamino-pyridin und 3,5-Diamino-2,6-dimethoxypyridin.M-Phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones, m-aminophenols and substituted pyridine derivatives are generally used as coupler components. Suitable coupler substances are, in particular, α-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethyl ether, m-phenylenediamine, 2,4 -Diaminophenoxyethanol, 2-amino-4- (2'-hydroxyethylamino) anisole, 1-phenyl-3-methyl-pyrazolon-5, 2,4-dichloro-3-aminophenol, 1, 3-bis- (2nd ', 4'-diaminophenoxy) propane, 2-chlororesorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 3-amino-6-methoxy-2- methylamino-pyridine and 3,5-diamino-2,6-dimethoxypyridine.
Bezüglich weiterer üblicher Farbstoffkomponenten wird ausdrücklich auf die Reihe „Derma- tology,,, herausgeben von Ch. Culnan, H. Maibach, Verlag Marcel Dekker Inc., New York, Basel, 1986, Bd. 7, Ch. Zviak, The Science of Hair Care, Kap. 7, Seiten 248 - 250 (Direktziehende Farbstoffe), und Kap. 8, Seiten 264 - 267 (Oxidationsfarbstoffe), sowie das „Europäische Inventar der Kosmetikrohstoffe,,, 1996, herausgegeben von der Europäischen Kommission, erhältlich in Diskettenform vom Bundesverband der deutschen Industrie- und Handelsunternehmen für Arzneimittel, Reformwaren und Körperpflegemittel e.V., Mannheim, Bezug genommen.With regard to other customary dye components, reference is expressly made to the “Dermatology” series, edited by Ch. Culnan, H. Maibach, Verlag Marcel Dekker Inc., New York, Basel, 1986, Vol. 7, Ch. Zviak, The Science of Hair Care, chap. 7, pages 248 - 250 (direct dyes), and chap. 8, pages 264 - 267 (oxidation dyes), as well as the "European Inventory of Cosmetic Raw Materials", 1996, published by the European Commission, available in disk form from the Federal Association of German Industry and Trade Companies for Medicines, Health Products and Personal Care Products, Mannheim, reference taken.
Häufig gelingt es mit den bekannten Färbemitteln nicht, eine auf dem Haar natürlich wirkende Farbnuance zu erhalten. Es besteht daher ständig Bedarf an neuen, verbesserten Farbstoff-Komponenten. Es war daher die Aufgabe der vorliegenden Erfindung, neue Komponenten zu finden, die geeignet sind, in Färbemitteln eingesetzt zu werden und die insbesondere die an Oxidationsfarbstoffvorprodukte zu stellenden Anforderungen in besonderem Maße erfüllen.Often it is not possible with the known coloring agents to obtain a color shade that looks natural on the hair. There is therefore a constant need for new, improved dye components. It was therefore the object of the present invention to find new components which are suitable for use in colorants and which in particular meet the requirements to be placed on oxidation dye precursors to a particular degree.
Es wurde gefunden, dass sich bestimmte Pyrazolderivate hervorragend als Färbekomponente in Mitteln zum Färben von keratinhaltigen Fasern eignen und auch die an Entwickler- komponenten gestellten Anforderungen in besonders hohem Maße erfüllen. So werden unter Verwendung dieser Entwicklerkomponenten mit den meisten bekannten Kupplerkomponenten brillante Farbnuancen, insbesondere im Rot- und Violettbereich, erhalten, die außerordentlich licht- und waschecht sind. Weiterhin zeichnen sich die erzielten Färbungen durch außerordentliche Kaltwellechtheit und Wärmestabilität, sowie durch eine hervorragende Egalisierung aus.It has been found that certain pyrazole derivatives are outstandingly suitable as a coloring component in agents for dyeing keratin-containing fibers, and also that of developer component requirements to a particularly high degree. Thus, using these developer components with most known coupler components, brilliant color shades are obtained, particularly in the red and violet range, which are extraordinarily lightfast and washable. Furthermore, the dyeings are characterized by extraordinary cold wave fastness and heat stability, as well as by an excellent leveling.
Gegenstand der vorliegenden Erfindung sind daher Mittel zum Färben von keratinhaltigen Fasern, enthaltend Oxidationsfarbstoffvorprodukte, dadurch gekennzeichnet, dass als Entwicklerkomponenten mindestens eine Verbindung mit der allgemeinen Formel I enthalten istThe present invention therefore relates to compositions for dyeing keratin-containing fibers containing oxidation dye precursors, characterized in that at least one compound of the general formula I is present as developer components
Figure imgf000005_0001
in der
Figure imgf000005_0001
in the
R1 und R2 gleich oder verschieden sein können und für Wasserstoff, C1-4-Alkyl oder C1-4-R1 and R2 can be the same or different and represent hydrogen, C 1-4 alkyl or C 1-4 -
Hydroxyalkyl stehen undHydroxyalkyl stand and
R3 steht für eine Gruppe mit der Formel II, (II),R3 stands for a group with the formula II, (II),
Figure imgf000005_0002
Figure imgf000005_0002
in der R4 für einen Piperazinylrest oder eine Gruppe -NR7(CH2)n-NR7 steht, in der R7 Wasserstoff oder C1-4-Alkyl und n eine ganze Zahl von 1 bis 4 sein können, R5 und R6 gleich oder verschieden sein können und Wasserstoff, C1-4-Alkyl oder C1-4- Hydroxyalkyl bedeuten,in which R4 represents a piperazinyl radical or a group -NR7 (CH 2 ) n -NR7, in which R7 is hydrogen or C 1-4 -alkyl and n can be an integer from 1 to 4, R5 and R6 are identical or different can be hydrogen, C 1-4 alkyl or C 1-4 hydroxyalkyl,
für eine Gruppe oder
Figure imgf000005_0003
for a group or
Figure imgf000005_0003
für eine Gruppe
Figure imgf000005_0004
in der R9 Wasserstoff, C1-4-Alkyl oder C1- -Hydroxyalkyl bedeutet, Y steht für eine direkte Bindung oder eine geradkettige oder verzweigte Cι-5- Alkylengruppe und
for a group
Figure imgf000005_0004
in which R9 is hydrogen, C 1-4 -alkyl or C 1- -hydroxyalkyl, Y represents a direct bond or a straight-chain or branched Cι -5 - alkylene group and
A steht für einen gesättigten oder ungesättigten, gegebenenfalls ein oder mehrere Heteroatome enthaltenden 5-, 6- oder 7-Ring, eine Gruppe -CO-NH2, eine Cι-4- Alkoxygruppe oder eine C1-4-Dialkylaminogruppe, wobei A mit jedem beliebigen Kohlenstoffatom der Alkylengruppe Y verknüpft sein kann.A stands for a saturated or unsaturated, optionally containing one or more heteroatoms 5-, 6- or 7-ring, a group -CO-NH 2 , a -C -4 - alkoxy group or a C 1-4 -dialkylamino group, where A with can be linked to any carbon atom of the alkylene group Y.
Unter keratinhaltigen Fasern sind dabei Pelze, Wolle, Federn und insbesondere menschliche Haare zu verstehen. Obwohl die erfindungsgemäßen Mittel in erster Linie zum Färben von Keratinfasern geeignet sind, steht prinzipiell einer Verwendung auch auf anderen Gebieten, insbesondere in der Farbphotographie, nichts entgegen.Fibers, wool, feathers and in particular human hair are to be understood as fibers containing keratin. Although the compositions according to the invention are primarily suitable for dyeing keratin fibers, there is in principle nothing to prevent them from being used in other areas, in particular in color photography.
Auch die physiologisch verträglichen Salze lassen sich in an sich bekannter Weise herstellen. Beispiele für solche Salze sind die Hydrochloride, die Hydrobromide, die Sulfate, die Phosphate, die Acetate, die Propionate, die Citrate und die Lactate.The physiologically tolerable salts can also be prepared in a manner known per se. Examples of such salts are the hydrochlorides, the hydrobromides, the sulfates, the phosphates, the acetates, the propionates, the citrates and the lactates.
In einer bevorzugten Ausführungsform der vorliegenden Erfindung steht R3 für eine Gruppe mit der Formel II. In dieser Ausführungsform haben sich insbesondere solche Verbindungen als geeignet erwiesen, in denen R1 und R6 sowie R2 und R5 jeweils gleich sind. Beispiele für bevorzugte Verbindungen, die unter diese Ausführungsform fallen sind (1 ,3-Dimethyl-4- aminopyrazol-5-yl)-(2-((1 ,3-dimethyl-4-aminopyrazol-5-yl)amino)ethyl)-amin und 1 ,4-Bis- (1 ,3-dimethyl-4-aminopyrazol-5-yl)-piperazin und deren physiologisch verträglichen Salze.In a preferred embodiment of the present invention, R3 stands for a group of the formula II. In this embodiment, those compounds have proven to be particularly suitable in which R1 and R6 and R2 and R5 are each the same. Examples of preferred compounds which fall under this embodiment are (1,3-dimethyl-4-aminopyrazol-5-yl) - (2 - ((1,3-dimethyl-4-aminopyrazol-5-yl) amino) ethyl) amine and 1,4-bis (1,3-dimethyl-4-aminopyrazol-5-yl) piperazine and their physiologically tolerable salts.
In einer weiteren bevorzugten Ausführungsform sind Verbindungen der Formel I bevorzugt, bei denen die Gruppe A steht für eine der Gruppen Piperidyl-, Morpholin-4-yl-, Imidazolyl-, Cyclopentyl-, Piperazinyl-, Pyrazolyl- oder Phenyl-. Weiterhin sind die Verbindungen der Formel I bevorzugt, bei denen Y steht für eine Ethylen- oder eine Propylengruppe. Besonders bevorzugt sind Verbindungen der Formel I, bei denen der Substituent -Y-A steht für einen 2-Piperidylethylrest, einen 2-(Morpholin-4'-yl)ethylrest, einen 3-(Morpholin-4'- yl)propylrest, einen 3-lmidazolylpropylrest, einen (N,N-Diethylamino)pentylrest, einen Cyclopentylrest, einen 2-Piperazinylethylrest, einen 2-Phenylethylrest oder einen 3- Ethoxypropylrest. Beispiele für derartig bevorzugte Verbindungen der Formel I sind (1 ,3-Dimethyl-4-aminopy- razol-5-yl)-(2-piperidylethyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-(morpholin-4'- yl)ethyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(3-(morpholin-4'-yl)propyl)-amin, 1 ,3-Di- methyl-4-amino-5-pyrazolylpyrazol, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(3-imidazolylpropyl)- amin, N-(4-((1,,3'-Dimethyl-4'-aminopyrazol-5'-yl)-amino)pentyl)-N,N-diethyl-amin, (1 ,3-Di- methyl-4-aminopyrazol-5-yl)-(cyclopentyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-pi- perazinylethyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-phenylethyl)-amin, 2-((4'-Amino- 1 ',3'-dimethylpyrazol-5'-yl)-amino)-acetamid, (4-Amino-1 ,3-dimethyl-pyrazol-5-yl)-(3-ethoxy- propyl)-amin und deren physiologisch verträglichen Salze.In a further preferred embodiment, compounds of the formula I are preferred in which the group A represents one of the groups piperidyl-, morpholin-4-yl-, imidazolyl-, cyclopentyl-, piperazinyl-, pyrazolyl- or phenyl-. The compounds of the formula I in which Y represents an ethylene or a propylene group are also preferred. Compounds of the formula I in which the substituent -YA represents a 2-piperidylethyl radical, a 2- (morpholin-4'-yl) ethyl radical, a 3- (morpholin-4'-yl) propyl radical, a 3- imidazolylpropyl, a (N, N-diethylamino) pentyl, a cyclopentyl, a 2-piperazinylethyl, a 2-phenylethyl or a 3-ethoxypropyl. Examples of such preferred compounds of the formula I are (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2-piperidylethyl) amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2- (morpholin-4'-yl) ethyl) amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (3- (morpholin-4'-yl) propyl) amine, 1 , 3-dimethyl-4-amino-5-pyrazolylpyrazol, (1, 3-dimethyl-4-aminopyrazole-5-yl) - (3-imidazolylpropyl) - amine, N- (4 - ((1, 3 '-Dimethyl-4'-aminopyrazol-5'-yl) -amino) pentyl) -N, N-diethyl-amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (cyclopentyl) - amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2-piperazinylethyl) amine, (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2-phenylethyl) - amine, 2 - ((4'-amino-1 ', 3'-dimethylpyrazol-5'-yl) amino) acetamide, (4-amino-1, 3-dimethylpyrazol-5-yl) - (3rd -ethoxy-propyl) -amine and their physiologically tolerable salts.
Es können auch beliebige Gemische von Verbindungen mit der Formel I sowie ggf. weiteren Farbstoffvorprodukten eingesetzt werden.Any mixtures of compounds with the formula I and, if appropriate, further dye precursors can also be used.
Die erfindungsgemäßen Mittel eignen sich besonders gut als sog. Oxidationsfärbemittel. In Oxidationsfärbemitteln wirkt die erfindungsgemäß eingesetzte Verbindung mit der Formel I als Entwickler-Komponente. Es können gewünschtenfalls noch weitere Entwickler-Komponenten sowie eine oder mehrere Kuppler-Komponenten enthalten sein.The agents according to the invention are particularly well suited as so-called oxidation coloring agents. In oxidation colorants, the compound of formula I used according to the invention acts as a developer component. If desired, further developer components as well as one or more coupler components can be included.
Als weitere Entwicklerkomponenten werden üblicherweise primäre aromatische Amine mit einer weiteren, in para- oder ortho-Position befindlichen, freien oder substituierten Hydroxy- oder Aminogruppe, Diaminopyridinderivate, heterocyclische Hydrazone, 4-Aminopyrazolde- rivate sowie 2,4,5,6-Tetraaminopyrimidin und dessen Derivate eingesetzt. Spezielle Vertreter sind beispielsweise p-Phenylendiamin, p-Toluylendiamin, 2,4,5,6-Tetraaminopyrimidin, p-Aminophenol, N,N-Bis(2'-hydroxyethyl)-p-phenylendiamin, 2-(2',5'-Diaminophenyl)- ethanol, 2-(2',5'-Diaminophenoxy)-ethanol, 4-Amino-3-methylphenol, 2-Aminomethyl-4- aminophenol, 4-Amino-2-diethylaminomethylphenol, 2-Hydroxy-4,5,6-triaminopyrimidin, 2,4- Dihydroxy-5,6-diaminopyrimidin, 2,5,6-Triamino-4-hydroxypyrimidin und 1 ,3-N,N'-Bis(2'- hydroxyethyl)-N,N'-bis(4'-aminophenyl)-diamino-propan-2-ol.Primary aromatic amines with a further free or substituted hydroxy or amino group in the para or ortho position, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine and. Are usually further developer components its derivatives used. Specific representatives are, for example, p-phenylenediamine, p-toluenediamine, 2,4,5,6-tetraaminopyrimidine, p-aminophenol, N, N-bis (2'-hydroxyethyl) -p-phenylenediamine, 2- (2 ', 5' -Diaminophenyl) - ethanol, 2- (2 ', 5'-diaminophenoxy) -ethanol, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol, 4-amino-2-diethylaminomethylphenol, 2-hydroxy-4, 5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, 2,5,6-triamino-4-hydroxypyrimidine and 1,3-N, N'-bis (2'-hydroxyethyl) -N, N '-bis (4'-aminophenyl) -diamino-propan-2-ol.
Ganz besonders bevorzugte weitere Entwicklerkomponenten sind p-Phenylendiamin, p-Toluylendiamin, N,N-Bis-(2'-hydroxyethyl)-p-phenylendiamin, 2,4,5,6-Tetraminopyrimidin, 1-(2'- Hydroxyethyl)-2,5-diaminobenzol, 3-Methyl-4-aminophenol, o-Aminophenol, 2-Aminomethyl- und 2-Hydroxymethyl-4-aminophenol. ln einer bevorzugten Ausführungsform enthält das erfindungsgemäße Mittel mindestens eine Kupplerkomponente.Very particularly preferred further developer components are p-phenylenediamine, p-toluenediamine, N, N-bis (2'-hydroxyethyl) -p-phenylenediamine, 2,4,5,6-tetraminopyrimidine, 1- (2'-hydroxyethyl) - 2,5-diaminobenzene, 3-methyl-4-aminophenol, o-aminophenol, 2-aminomethyl and 2-hydroxymethyl-4-aminophenol. In a preferred embodiment, the agent according to the invention contains at least one coupler component.
Als Kupplerkomponenten werden in der Regel m-Phenylendiaminderivate, Naphthole, Re- sorcin und Resorcinderivate, Pyrazolone und m-Aminophenolderivate verwendet.M-Phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are generally used as coupler components.
Erfindungsgemäß bevorzugte Kupplerkomponenten sind m-Aminophenol und dessen Derivate wie beispielsweise 5-Amino-2-methylphenol, 3- Amino-2-chlor-6-methylphenol, 2-Hydroxy-4-aminophenoxyethanol, 2,6-Dimethyl-3-ami- nophenol, 3-Trifluoroacetylamino-2-chlor-6-methylphenol, 5-Amino-4-chlor-2-methylphe- nol, 5-Amino-4-methoxy-2-methylphenol, 5-(2'-Hydroxyethyl)-amino-2-methylphenol, 3- (Diethylamino)-phenol, N-Cyclopentyl-3-aminophenol, 1 ,3-Dihydroxy-5-(methylamino)- benzol, 3-(Ethylamino)-4-methylphenol und 2,4-Dichlor-3-aminophenol,Coupler components preferred according to the invention are m-aminophenol and its derivatives such as 5-amino-2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 2,6-dimethyl-3-ami- nophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5- (2'-hydroxyethyl) amino -2-methylphenol, 3- (diethylamino) phenol, N-cyclopentyl-3-aminophenol, 1, 3-dihydroxy-5- (methylamino) benzene, 3- (ethylamino) -4-methylphenol and 2,4-dichloro -3-aminophenol,
- o-Aminophenol und dessen Derivate, m-Diaminobenzol und dessen Derivate wie beispielsweise 2,4-Diaminophenoxyethanol,o-aminophenol and its derivatives, m-diaminobenzene and its derivatives such as 2,4-diaminophenoxyethanol,
1 ,3-Bis-(2,4-diaminophenoxy)-propan, 1-Methoxy-2-amino-4-(2'-hydroxyethylamino)ben- zol, 1 ,3-Bis-(2,4-diaminophenyl)-propan, 2,6-Bis-(2-hydroxyethylamino)-1-methylbenzol und 1 -Amino-3-bis-(2'-hydroxyethyl)-aminobenzol, o-Diaminobenzol und dessen Derivate wie beispielsweise 3,4-Diaminobenzoesäure und1,3-bis (2,4-diaminophenoxy) propane, 1-methoxy-2-amino-4- (2'-hydroxyethylamino) benzene, 1,3-bis (2,4-diaminophenyl) - propane, 2,6-bis (2-hydroxyethylamino) -1-methylbenzene and 1-amino-3-bis (2'-hydroxyethyl) aminobenzene, o-diaminobenzene and its derivatives such as 3,4-diaminobenzoic acid and
2,3-Diamino-1 -methylbenzol,2,3-diamino-1-methylbenzene,
Di- beziehungsweise Trihydroxybenzolderivate wie beispielsweise Resorcin, Resorcin- monomethylether, 2-Methylresorcin, 5-Methylresorcin, 2,5-Dimethylresorcin, 2-Chlorre- sorcin, 4-Chlorresorcin, Pyrogallol und 1 ,2,4-Trihydroxybenzol,Di- or trihydroxybenzene derivatives such as resorcinol, resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1, 2,4-trihydroxybenzene,
Pyridinderivate wie beispielsweise 2,6-Dihydroxypyridin, 2-Amino-3-hydroxypyhdin, 2-Pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyhdin, 2-
Amino-5-chlor-3-hydroxypyridin, 3-Amino-2-methylamino-6-methoxypyridin, 2,6-Dihy- droxy-3,4-dimethylpyridin, 2,6-Dihydroxy-4-methylpyridin, 2,6-Diaminopyridin, 2,3-Diami- no-6-methoxypyridin und 3,5-Diamino-2,6-dimethoxypyridin,Amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6- Diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine,
- Naphthalinderivate wie beispielsweise 1-Naphthol, 2-Methyl-1-naphthol, 2-Hydroxyme- thyl-1-naphthol, 2-Hydroxyethyl-1-naphthol, 1 ,5-Dihydroxynaphthalin, 1 ,6-Dihydroxy- naphthalin, 1 ,7-Dihydroxynaphthalin, 1 ,8-Dihydroxynaphthalin, 2,7-Dihydroxynaphthalin und 2,3-Dihydroxynaphthalin,Naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1, 5-dihydroxynaphthalene, 1, 6-dihydroxy-naphthalene, 1, 7-dihydroxynaphthalene, 1, 8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene,
Morpholinderivate wie beispielsweise 6-Hydroxybenzomorpholin und 6-Amino-benzo- morpholin,Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-amino-benzomorpholine,
- Chinoxalinderivate wie beispielsweise 6-Methyl-1 ,2,3,4-tetrahydrochinoxalin, Pyrazolderivate wie beispielsweise 1-Phenyl-3-methylpyrazol-5-on, - Indolderivate wie beispielsweise 4-Hydroxyindol, 6-Hydroxyindol und 7-Hydroxyindol,Quinoxaline derivatives such as 6-methyl-1, 2,3,4-tetrahydroquinoxaline, pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one, Indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole,
- Pyrimidinderivate, wie beispielsweise 4,6-Diaminopyrimidin, 4-Amino-2,6-dihydroxypyri- midin, 2,4-Diamino-6-hydroxypyrimidin, 2,4,6-Trihydroxypyrimidin, 2-Amino-4-methylpy- rimidin, 2-Amino-4-hydroxy-6-methylpyrimidin und 4,6-Dihydroxy-2-methylpyrimidin, oder- Pyrimidine derivatives, such as 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4-methylpyrimidine , 2-amino-4-hydroxy-6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine, or
- Methylendioxybenzolderivate wie beispielsweise 1-Hydroxy-3,4-methylendioxybenzol, 1- Amino-3,4-methylendioxybenzol und 1 -(2'-Hydroxyethyl)-amino-3,4-methylendioxyben- zol.- Methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1 - (2'-hydroxyethyl) amino-3,4-methylenedioxybenzene.
Besonders bevorzugte Kupplerkomponenten sind 1-Naphthol, 1 ,5-, 2,7- und 1 ,7-Dihydroxy- naphthalin, 3-Aminophenol, 5-Amino-2-methylphenol, 2-Amino-3-hydroxypyridin, Resorcin, 4-Chlorresorcin, 2-Chlor-6-methyl-3-aminophenol, 2-Methylresorcin, 5-Methylresorcin, 2,5- Dimethylresorcin und 2,6-Dihydroxy-3,4-dimethylpyridin.Particularly preferred coupler components are 1-naphthol, 1, 5-, 2,7- and 1, 7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4- Chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
Diese weiteren Entwickler- und Kupplerkomponenten werden üblicherweise in freier Form eingesetzt. Bei Substanzen mit Aminogruppen kann es aber bevorzugt sein, sie in Salzform, insbesondere in Form der Hydrochloride und Sulfate, einzusetzen.These further developer and coupler components are usually used in free form. For substances with amino groups, however, it can be preferred to use them in salt form, in particular in the form of the hydrochlorides and sulfates.
Die erfindungsgemäßen Mittel enthalten die Verbindungen mit der Formel I und die ggf. vorhandenen Kupplerkomponenten bevorzugt in einer Menge von 0,005 bis 20 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, jeweils bezogen auf das gesamte Mittel. Dabei werden die einzelnen Komponenten vorzugsweise in etwa molaren Mengen zueinander eingesetzt. Wenn sich auch der molare Einsatz als zweckmäßig erwiesen hat, so ist ein gewisser Überschuß einzelner Oxidationsfarbstoffvorprodukte nicht nachteilig, so dass Entwicklerkomponenten und Kupplerkomponenten in einem Mol-Verhältnis von 1 : 0,5 bis 1 : 3, insbesondere 1 :1 bis 1 :2, enthalten sein können.The agents according to the invention preferably contain the compounds of formula I and any coupler components present in an amount of 0.005 to 20% by weight, preferably 0.1 to 5% by weight, each based on the total agent. The individual components are preferably used in approximately molar amounts to one another. If molar use has also proven to be expedient, a certain excess of individual oxidation dye precursors is not disadvantageous, so that developer components and coupler components in a molar ratio of 1: 0.5 to 1: 3, in particular 1: 1 to 1: 2 , can be included.
In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Mittel zur weiteren Modifizierung der Farbnuancen neben den erfindungsgemäß enthaltenen Verbindungen zusätzlich übliche direktziehende Farbstoffe, z. B. aus der Gruppe der Nitrophenylendia- mine, Nitroaminophenole, Azofarbstoffe, Anthrachinone oder Indophenole. Bevorzugte direktziehende Farbstoffe sind die unter den internationalen Bezeichnungen bzw. Handelsnamen HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, Basic Yellow 57, Disperse Orange 3, HC Red 3, HC Red BN, Basic Red 76, HC Blue 2, HC Blue 12, Disperse Blue 3, Basic Blue 99, HC Violet 1 , Disperse Violet 1 , Disperse Violet 4, Disperse Black 9, Basic Brown 16 und Basic Brown 17 bekannten Verbindungen sowie 1 ,4-Bis-(2'-hydroxyethyl)- amino-2-nitrobenzol, 3-Nitro-4-(2'-hydroxyethyl)-aminophenol, 4-Amino-2-nitrodiphenylamin- 2'-carbonsäure, 6-Nitro-1 ,2,3,4-tetrahydrochinoxalin, 2-Hydroxy-1 ,4-naphthochinon, Hy- droxyethyl-2-nitro-toluidin, Pikraminsäure, 2-Amino-6-chloro-4-nitrophenol, 4-Ethylamino-3- nitrobenzoesäure und 2-Chloro-6-ethylamino-1-hydroxy-4-nitrobenzol. Die erfindungsgemäßen Mittel gemäß dieser Ausführungsform enthalten die direktziehenden Farbstoffe bevorzugt in einer Menge von 0,01 bis 20 Gew.-%, bezogen auf das gesamte Färbemittel.In a preferred embodiment, the agents according to the invention contain, in addition to the compounds contained according to the invention, customary direct dyes, e.g. B. from the group of nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols. Preferred direct dyes are those with the international names or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, Basic Yellow 57, Disperse Orange 3, HC Red 3, HC Red BN, Basic Red 76, HC Blue 2, HC Blue 12, Disperse Blue 3, Basic Blue 99, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Disperse Black 9, Basic Brown 16 and Basic Brown 17 known compounds as well as 1,4-bis- (2'- hydroxyethyl) - amino-2-nitrobenzene, 3-nitro-4- (2'-hydroxyethyl) aminophenol, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1, 2,3,4-tetrahydroquinoxaline, 2- Hydroxy-1, 4-naphthoquinone, hydroxyethyl-2-nitro-toluidine, picraminic acid, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1- hydroxy-4-nitrobenzene. The agents according to the invention in accordance with this embodiment preferably contain the substantive dyes in an amount of 0.01 to 20% by weight, based on the total colorant.
Weiterhin können die erfindungsgemäßen Zubereitungen auch in der Natur vorkommende Farbstoffe wie beispielsweise Henna rot, Henna neutral, Henna schwarz, Kamillenblüte, Sandelholz, schwarzer Tee, Faulbaumrinde, Salbei, Blauholz, Krappwurzel, Catechu, Sedre und Alkannawurzel enthalten.Furthermore, the preparations according to the invention can also contain naturally occurring dyes such as, for example, henna red, henna neutral, henna black, chamomile flowers, sandalwood, black tea, rotten tree bark, sage, blue wood, madder root, catechu, sedre and alkanna root.
Es ist nicht erforderlich, dass die Oxidationsfarbstoffvorprodukte oder die fakultativ enthaltenen direktziehenden Farbstoffe jeweils einheitliche Verbindungen darstellen. Vielmehr können in den erfindungsgemäßen Mitteln, bedingt durch die Herstellungsverfahren für die einzelnen Farbstoffe, in untergeordneten Mengen noch weitere Komponenten enthalten sein, soweit diese nicht das Färbeergebnis nachteilig beeinflussen oder aus anderen Gründen, z. B. toxikologischen, ausgeschlossen werden müssen.It is not necessary that the oxidation dye precursors or the optional direct dyes each represent uniform compounds. Rather, in the agents according to the invention, due to the manufacturing process for the individual dyes, further components may be contained in minor amounts, provided that these do not adversely affect the coloring result or for other reasons, e.g. B. toxicological, must be excluded.
Weitere in den erfindungsgemäßen Mitteln enthaltene Farbstoffkomponenten können auch Indole und Indoline, sowie deren physiologisch verträgliche Salze, sein. Bevorzugte Beispiele sind 5,6-Dihydroxyindol, N-Methyl-5,6-dihydroxyindol, N-Ethyl-5,6-dihydroxyindol, N- Propyl-5,6-dihydroxyindol, N-Butyl-5,6-dihydroxyindol, 6-Hydroxyindol, 6-Aminoindol und 4- Aminoindol. Weiterhin bevorzugt sind 5,6-Dihydroxyindolin, N-Methyl-5,6-dihydroxyindolin, N-Ethyl-5,6-dihydroxyindolin, N-Propyl-5,6-dihydroxyindolin, N-Butyl-5,6-dihydroxyindolin, 6- Hydroxyindolin, 6-Aminoindolin und 4-Aminoindolin.Further dye components contained in the agents according to the invention can also be indoles and indolines, as well as their physiologically tolerable salts. Preferred examples are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, 6 -Hydroxyindole, 6-aminoindole and 4-aminoindole. Also preferred are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline, 6 - hydroxyindoline, 6-aminoindoline and 4-aminoindoline.
Die erfindungsgemäßen Mittel ergeben bereits bei physiologisch verträglichen Temperaturen von unter 45°C intensive Färbungen. Sie eignen sich deshalb besonders zum Färben von menschlichen Haaren. Zur Anwendung auf dem menschlichen Haar können die Mittel üblicherweise in einen wasserhaltigen kosmetischen Träger eingearbeitet werden. Geeignete wasserhaltige kosmetische Träger sind z. B. Cremes, Emulsionen, Gele oder auch ten- sidhaltige schäumende Lösungen wie z. B. Shampoos oder andere Zubereitungen, die für die Anwendung auf den keratinhaltigen Fasern geeignet sind. Falls erforderlich ist es auch möglich, die Mittel in wasserfreie Träger einzuarbeiten. Weiterhin können die erfindungsgemäßen Mittel alle in solchen Zubereitungen bekannten Wirk-, Zusatz- und Hilfsstoffe enthalten. In vielen Fällen enthalten die Mittel mindestens ein Tensid, wobei prinzipiell sowohl anionische als auch zwitterionische, ampholytische, nichtionische und kationische Tenside geeignet sind. In vielen Fällen hat es sich aber als vorteilhaft erwiesen, die Tenside aus anionischen, zwitterionischen oder nichtionischen Tensiden auszuwählen.The agents according to the invention produce intensive colorations even at physiologically compatible temperatures of below 45 ° C. They are therefore particularly suitable for dyeing human hair. For use on human hair, the agents can usually be incorporated into a water-containing cosmetic carrier. Suitable water-containing cosmetic carriers are e.g. B. creams, emulsions, gels or surfactant-containing foaming solutions such. B. shampoos or other preparations that are suitable for use on the keratin fibers. If necessary, it is also possible to incorporate the agents into anhydrous carriers. Furthermore, the agents according to the invention can contain all active ingredients, additives and auxiliaries known in such preparations. In many cases, the agents contain at least one surfactant, and in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable. In many cases, however, it has proven advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
Als anionische Tenside eignen sich in erfindungsgemäßen Zubereitungen alle für die Verwendung am menschlichen Körper geeigneten anionischen oberflächenaktiven Stoffe. Diese sind gekennzeichnet durch eine wasserlöslich machende, anionische Gruppe wie z. B. eine Carboxylat-, Sulfat-, Sulfonat- oder Phosphat-Gruppe und eine lipophile Alkyl- gruppe mit etwa 10 bis 22 C-Atomen. Zusätzlich können im Molekül Glykol- oder Polyglykol- ether-Gruppen, Ester-, Ether- und Amidgruppen sowie Hydroxylgruppen enthalten sein. Beispiele für geeignete anionische Tenside sind, jeweils in Form der Natrium-, Kalium- und Ammonium- sowie der Mono-, Di- und Trialkanolammoniumsalze mit 2 oder 3 C-Atomen in der Alkanolgruppe,Suitable anionic surfactants in preparations according to the invention are all anionic surface-active substances suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 10 to 22 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups can be contained in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts with 2 or 3 carbon atoms in the alkanol group,
lineare Fettsäuren mit 10 bis 22 C-Atomen (Seifen),linear fatty acids with 10 to 22 carbon atoms (soaps),
Ethercarbonsäuren der Formel R-O-(CH2-CH2O)x-CH2-COOH, in der R eine lineare Al- kylgruppe mit 10 bis 22 C-Atomen und x = 0 oder 1 bis 16 ist, Acylsarcoside mit 10 bis 18 C-Atomen in der Acylgruppe, Acyltauhde mit 10 bis 18 C-Atomen in der Acylgruppe, Acylisethionate mit 10 bis 18 C-Atomen in der Acylgruppe,Ether carboxylic acids of the formula RO- (CH 2 -CH 2 O) x -CH 2 -COOH, in which R is a linear alkyl group with 10 to 22 C atoms and x = 0 or 1 to 16, acyl sarcosides with 10 to 18 C atoms in the acyl group, Acyltauhde with 10 to 18 C atoms in the acyl group, Acyl isethionates with 10 to 18 C atoms in the acyl group,
Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 18 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremono-alkylpolyoxyethylester mit 8 bis 18 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen, lineare Alkansulfonate mit 12 bis 18 C-Atomen, lineare Alpha-Olefinsulfonate mit 12 bis 18 C-Atomen, Alpha-Sulfofettsäuremethylester von Fettsäuren mit 12 bis 18 C-Atomen, Alkylsulfate und Alkylpolyglykolethersulfate der Formel R-O(CH2-CH2O)x-SO3H, in der R eine bevorzugt lineare Alkylgruppe mit 10 bis 18 C-Atomen und x = 0 oder 1 bis 12 ist, Gemische oberflächenaktiver Hydroxysulfonate gemäß DE-A-37 25 030, sulfatierte Hydroxyalkylpolyethylen- und/oder Hydroxyalkylenpropylenglykolether gemäß DE-A-37 23 354,Sulfosuccinic acid mono- and dialkyl esters with 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid mono-alkyl polyoxyethyl esters with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates with 12 to 18 carbon atoms, linear alpha-olefin sulfonates with 12 to 18 carbon atoms, alpha-sulfofatty acid methyl ester of fatty acids with 12 to 18 carbon atoms, alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -SO 3 H, in which R is a preferably linear alkyl group with 10 to 18 C atoms and x = 0 or 1 to 12, mixtures of surface-active hydroxysulfonates according to DE-A-37 25 030, sulfated hydroxyalkyl polyethylene and / or hydroxyalkylene propylene glycol ethers according to DE-A-37 23 354,
Sulfonate ungesättigter Fettsäuren mit 12 bis 24 C-Atomen und 1 bis 6 Doppelbindungen gemäß DE-A-39 26 344,Sulfonates of unsaturated fatty acids with 12 to 24 carbon atoms and 1 to 6 double bonds according to DE-A-39 26 344,
Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2 bis 15 Molekülen Ethylenoxid und/oder Propylenoxid an Fettalkohole mit 8 bis 22 C-Atomen darstellen.Esters of tartaric acid and citric acid with alcohols, the addition products of about 2 to 15 molecules of ethylene oxide and / or propylene oxide to fatty alcohols with 8 to 22 carbon atoms.
Bevorzugte anionische Tenside sind Alkylsulfate, Alkylpolyglykolethersulfate und Ethercar- bonsäuren mit 10 bis 18 C-Atomen in der Alkylgruppe und bis zu 12 Glykolethergruppen im Molekül sowie insbesondere Salze von gesättigten und insbesondere ungesättigten C8-C22- Carbonsäuren, wie Ölsäure, Stearinsäure, Isostearinsäure und Palmitinsäure.Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids with 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, and in particular salts of saturated and in particular unsaturated C 8 -C 22 carboxylic acids, such as oleic acid, stearic acid, isostearic acid and palmitic acid.
Als zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine -COO(_)- oder -Sθ3 H-Gruppe tragen. Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Alkyl-N,N-dimethylammonium-glycinate, beispielsweise das Kokosalkyl-dimethylammoniumglycinat, N-Acyl-aminopropyl-N,N-dimethylammoniumglyci- nate, beispielsweise das Kokosacylaminopropyl-dimethylammoniumglycinat, und 2-Alkyl-3- carboxymethyl-3-hydroxyethyl-imidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. Ein bevorzugtes zwitterionisches Tensid ist das unter der CTFA-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid-Derivat.Zwitterionic surfactants are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO (_) - or -Sθ 3 H group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example coconut alkyl dimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example coconut acylaminopropyl dimethylammonium glycinate, and 2 -Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine.
Unter ampholytischen Tensiden werden solche oberflächenaktiven Verbindungen verstanden, die außer einer C8-18-Alkyl- oder -Acylgruppe im Molekül mindestens eine freie Amino- gruppe und mindestens eine -COOH- oder -SO3H-Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete ampholytische Tenside sind N-Alkylgly- cine, N-Alkylpropionsäuren, N-Alkylaminobuttersäuren, N-Alkyliminodipropionsäuren, N-Hy- droxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkylaminopropi- onsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 18 C-Atomen in der Alkylgruppe. Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropio- nat, das Kokosacylaminoethylaminopropionat und das C12-ι8-Acylsarcosin. Nichtionische Tenside enthalten als hydrophile Gruppe z. B. eine Polyolgruppe, eine Polyal- kylenglykolethergruppe oder eine Kombination aus Polyol- und Polyglykolethergruppe. Solche Verbindungen sind beispielsweiseAmpholytic surfactants are surface-active compounds which, in addition to a C 8-18 alkyl or acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and are capable of forming internal salts are. Examples of suitable ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkyl sarcosine, 2-alkylaminopropionic acid and alkylaminoacetic acid each about 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-Kokosalkylaminopropio- nat, cocoacylaminoethyl aminopropionate and C 12- ι 8 acyl sarcosine. Nonionic surfactants contain z as a hydrophilic group. B. a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group. Such connections are, for example
Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe, C12-22-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin,Addition products of 2 to 30 mol ethylene oxide and / or 0 to 5 mol propylene oxide with linear fatty alcohols with 8 to 22 carbon atoms, with fatty acids with 12 to 22 carbon atoms and with alkylphenols with 8 to 15 carbon atoms in the alkyl group, C 12-22 fatty acid monoesters and diesters of adducts of 1 to 30 moles of ethylene oxide with glycerol,
C8-22-Alkylmono- und -oligoglycoside und deren ethoxylierte Analoga, Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,C 8-22 alkyl mono- and oligoglycosides and their ethoxylated analogues, addition products of 5 to 60 mol ethylene oxide onto castor oil and hardened castor oil,
Anlagerungeprodukte von Ethylenoxid an Sorbitanfettsäureester Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide.Addition products of ethylene oxide with sorbitan fatty acid esters Addition products of ethylene oxide with fatty acid alkanolamides.
Beispiele für die in den erfindungsgemäßen Haarbehandlungsmitteln verwendbaren kationischen Tenside sind insbesondere quartäre Ammoniumverbindungen. Bevorzugt sind Ammoniumhalogenide wie Alkyltrimethylammoniumchloride, Dialkyldimethylammoniumchloride und Trialkylmethylam oniumchloride, z. B. Cetyltrimethylammoniumchlorid, Stearyltrime- thylammoniumchlorid, Distearyldimethylammoniumchlorid, Lauryldimethylammoniumchlorid, Lauryldimethylbenzylammoniumchlorid und Tricetylmethylammoniumchlorid. Weitere erfindungsgemäß verwendbare kationische Tenside stellen die quaternisierten Proteinhydroly- sate dar.Examples of the cationic surfactants which can be used in the hair treatment compositions according to the invention are, in particular, quaternary ammonium compounds. Ammonium halides such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylam onium chlorides, e.g. B. cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride. The quaternized protein hydrolysates are further cationic surfactants which can be used according to the invention.
Erfindungsgemäß ebenfalls geeignet sind kationische Silikonöle wie beispielsweise die im Handel erhältlichen Produkte Q2-7224 (Hersteller: Dow Corning; ein stabilisiertes Trimethyl- silylamodimethicon), Dow Corning 929 Emulsion (enthaltend ein hydroxyl-amino-modifizier- tes Silicon, das auch als Amodimethicone bezeichnet wird), SM-2059 (Hersteller: General Electric), SLM-55067 (Hersteller: Wacker) sowie Abil®-Quat 3270 und 3272 (Hersteller: Th. Goldschmidt; diquaternäre Polydimethylsiloxane, Quaternium-80).Also suitable according to the invention are cationic silicone oils such as, for example, the commercially available products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone, which is also referred to as amodimethicone) will), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt; diquaternary polydimethylsiloxanes, Quaternium-80).
Alkylamidoamine, insbesondere Fettsäureamidoamine wie das unter der Bezeichnung Tego Amid®S 18 erhältliche Stearylamidopropyldimethylamin, zeichnen sich neben einer guten konditionierenden Wirkung speziell durch ihre gute biologische Abbaubarkeit aus. Ebenfalls sehr gut biologisch abbaubar sind quaternäre Esterverbindungen, sogenannte "Esterquats", wie die unter dem Warenzeichen Stepantex® vertriebenen Methylhydroxyalkyl- dialkoyloxyalkylammoniummethosulfate.In addition to a good conditioning effect, alkylamidoamines, especially fatty acid amidoamines such as the stearylamidopropyldimethylamine available under the name Tego Amid ® S 18, are notable for their good biodegradability. Also very good biodegradability are quaternary Esterverbindungen, so-called "esterquats", dialkoyloxyalkylammoniummethosulfate such as those sold under the trademark Stepantex ® methyl hydroxyalkyl.
Ein Beispiel für ein als kationisches Tensid einsetzbares quaternäres Zuckerderivat stellt das Handelsprodukt Glucquat®100 dar, gemäß CTFA-Nomenklatur ein "Lauryl Methyl Glu- ceth-10 Hydroxypropyl Dimonium Chloride".An example of a suitable cationic surfactant quaternary sugar derivative is the commercial product Glucquat ® 100, according to CTFA nomenclature a "lauryl methyl Gluceth-10 Hydroxypropyl Dimonium Chloride".
Bei den als Tenside eingesetzten Verbindungen mit Alkylgruppen kann es sich jeweils um einheitliche Substanzen handeln. Es ist jedoch in der Regel bevorzugt, bei der Herstellung dieser Stoffe von nativen pflanzlichen oder tierischen Rohstoffen auszugehen, so dass man Substanzgemische mit unterschiedlichen, vom jeweiligen Rohstoff abhängigen Alkylketten- längen erhält.The compounds with alkyl groups used as surfactants can each be uniform substances. However, it is generally preferred to start from natural vegetable or animal raw materials in the production of these substances, so that substance mixtures with different alkyl chain lengths depending on the respective raw material are obtained.
Bei den Tensiden, die Anlagerungsprodukte von Ethylen- und/oder Propylenoxid an Fettalkohole oder Derivate dieser Anlagerungsprodukte darstellen, können sowohl Produkte mit einer "normalen" Homologenverteilung als auch solche mit einer eingeengten Homologenverteilung verwendet werden. Unter "normaler" Homologenverteilung werden dabei Mischungen von Homologen verstanden, die man bei der Umsetzung von Fettalkohol und Al- kylenoxid unter Verwendung von Alkalimetallen, Alkalimetallhydroxiden oder Alkalimetallal- koholaten als Katalysatoren erhält. Eingeengte Homologenverteilungen werden dagegen erhalten, wenn beispielsweise Hydrotalcite, Erdalkalimetallsalze von Ethercarbonsäuren, Erdalkalimetalloxide, -hydroxide oder -alkoholate als Katalysatoren verwendet werden. Die Verwendung von Produkten mit eingeengter Homologenverteilung kann bevorzugt sein.In the case of the surfactants, which are addition products of ethylene and / or propylene oxide onto fatty alcohols or derivatives of these addition products, both products with a "normal" homolog distribution and those with a narrowed homolog distribution can be used. “Normal” homolog distribution is understood to mean mixtures of homologs which are obtained as catalysts from the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates. In contrast, narrow homolog distributions are obtained if, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with a narrow homolog distribution can be preferred.
Weitere Wirk-, Hilfs- und Zusatzstoffe sind beispielsweise nichtionische Polymere wie beispielsweise Vinylpyrrolidon/Vinylacrylat-Copolymere, Polyvinylpyrrolidon und Vinylpyrrolidon/Vinylacetat-Copolymere und Polysiloxane, kationische Polymere wie quaternisierte Celluloseether, Polysiloxane mit quaternären Gruppen, Dimethyldiallylammoniumchlorid-Polymere, Acrylamid-Dimethyldiallylammo- niumchlorid-Copolymere, mit Diethylsulfat quaternierte Dimethylaminoethylmethacrylat- Vinylpyrrolidon-Copolymere, Vinylpyrrolidon-Imidazoliniummethochlorid-Copolymere und quaternierter Polyvinylalkohol, zwitterionische und amphotere Polymere wie beispielsweise Acrylamidopropyl-trime- thylammoniumchlorid/Acrylat-Copolymere und Octylacrylamid/Methylmethacrylat/tert.- Butylaminoethylmethacrylat/2-Hydroxypropylmethacrylat-Copolymere, anionische Polymere wie beispielsweise Polyacrylsäuren, vernetzte Polyacrylsäuren, Vinylacetat/Crotonsäure-Copolymere, VinylpyrrolidonΛ/inylacrylat-Copolymere, Vinyl- acetat/Butylmaleat/lsobomylacrylat-Copolymere, Methylvinylether/Maleinsäureanhy- drid-Copolymere und Acrylsäure/Ethylacrylat/N-tert.-Butylacrylamid-Terpolymere, Verdickungsmittel wie Agar-Agar, Guar-Gum, Alginate, Xanthan-Gum, Gummi arabi- cum, Karaya-Gummi, Johannisbrotkernmehl, Leinsamengummen, Dextrane, Cellulose- Derivate, z. B. Methylcellulose, Hydroxyalkylcellulose und Carboxymethylcellulose, Stärke-Fraktionen und Derivate wie Amylose, Amylopektin und Dextrine, Tone wie z. B. Bentonit oder vollsynthetische Hydrokolloide wie z. B. Polyvinylalkohol, Strukturanten wie Glucose und Maleinsäure, haarkonditionierende Verbindungen wie Phospholipide, beispielsweise Sojalecithin, Ei- Lecitin und Kephaline, sowie Silikonöle,Other active ingredients, auxiliaries and additives are, for example, nonionic polymers such as, for example, vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers and polysiloxanes, cationic polymers such as quaternized cellulose ethers, polysiloxanes with quaternary groups, dimethyldioxylammonylammonylammonylammonylammonylammonyl amide Copolymers, dimethylaminoethyl methacrylate quaternized with diethyl sulfate, vinyl pyrrolidone copolymers, vinyl pyrrolidone imidazolinium methochloride copolymers and quaternized polyvinyl alcohol, zwitterionic and amphoteric polymers such as acrylamidopropyl-trimethylammonium chloride / acrylate copolymers and octylacrylamide / methyl methacrylate / tert.-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, anionic polymers such as polyacrylic acids, cross-linked polyacrylic acids, vinyl acetate / crotonic acid / vinyl acrylate / crononic acid / vinyl alcohol Copolymers, vinyl acetate / butyl maleate / isobomylacrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and acrylic acid / ethyl acrylate / N-tert-butylacrylamide terpolymers, thickeners such as agar agar, guar gum, alginates, xanthan gum, rubber arabic cum, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. B. methyl cellulose, hydroxyalkyl cellulose and carboxymethyl cellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. B. bentonite or fully synthetic hydrocolloids such. B. polyvinyl alcohol, structurants such as glucose and maleic acid, hair conditioning compounds such as phospholipids, for example soy lecithin, egg lecithin and cephalins, and silicone oils,
Proteinhydrolysate, insbesondere Elastin-, Kollagen-, Keratin-, Milcheiweiß-, Sojaprotein- und Weizenproteinhydrolysate, deren Kondensationsprodukte mit Fettsäuren sowie quatemisierte Proteinhydrolysate, Parfümöle, Dimethylisosorbid und Cyclodextrine,Protein hydrolyzates, in particular elastin, collagen, keratin, milk protein, soy protein and wheat protein hydrolyzates, their condensation products with fatty acids and quaternized protein hydrolyzates, perfume oils, dimethyl isosorbide and cyclodextrins,
Lösungsvermittler wie Ethanol, Isopropanol, Ethylenglykol, Propylenglykol, Glycerin und Diethylenglykol,Solubilizers such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerin and diethylene glycol,
Antischuppenwirkstoffe wie Piroctone Olamine und Zink Omadine, weitere Substanzen zur Einstellung des pH-Wertes,Anti-dandruff agents such as piroctone olamine and zinc omadine, other substances for adjusting the pH value,
Wirkstoffe wie Panthenol, Pantothensäure, Allantoin, Pyrrolidoncarbonsäuren und deren Salze, Pflanzenextrakte und Vitamine, Cholesterin, Lichtschutzmittel,Active ingredients such as panthenol, pantothenic acid, allantoin, pyrrolidone carboxylic acids and their salts, plant extracts and vitamins, cholesterol, light stabilizers,
Konsistenzgeber wie Zuckerester, Polyolester oder Polyolalkylether, Fette und Wachse wie Walrat, Bienenwachs, Montanwachs, Paraffine, Fettalkohole und Fettsäureester, Fettsäurealkanolamide,Consistency enhancers such as sugar esters, polyol esters or polyol alkyl ethers, fats and waxes such as walrus, beeswax, montan wax, paraffins, fatty alcohols and fatty acid esters, fatty acid alkanolamides,
Komplexbildner wie EDTA, NTA und Phosphonsäuren,Complexing agents such as EDTA, NTA and phosphonic acids,
Quell- und Penetrationsstoffe wie Glycerin, Propylenglykolmonoethylether, Carbonate, Hydrogencarbonate, Guanidine, Harnstoffe sowie primäre, sekundäre und tertiäre Phosphate, Imidazole, Tannine, Pyrrol, Trübungsmittel wie Latex,Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates, hydrogen carbonates, guanidines, ureas and primary, secondary and tertiary phosphates, imidazoles, tannins, pyrrole, Opacifiers like latex,
Perlglanzmittel wie Ethylenglykolmono- und -distearat,Pearlescent agents such as ethylene glycol mono- and distearate,
Treibmittel wie Propan-Butan-Gemische, N2O, Dimethylether, CO2 und Luft sowieBlowing agents such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air as well
Antioxidantien.Antioxidants.
Die Bestandteile des wasserhaltigen Trägers werden zur Herstellung der erfindungsgemäßen Mittel in für diesen Zweck üblichen Mengen eingesetzt; z. B. werden Emulgiermittel in Konzentrationen von 0,5 bis 30 Gew.-% und Verdickungsmittel in Konzentrationen von 0,1 bis 25 Gew.-% des gesamten Mittels eingesetzt.The constituents of the water-containing carrier are used for the preparation of the agents according to the invention in amounts customary for this purpose; z. For example, emulsifiers are used in concentrations of 0.5 to 30% by weight and thickeners in concentrations of 0.1 to 25% by weight of the total agent.
Für das Färbeergebnis kann es vorteilhaft sein, den Mitteln Ammonium- oder Metallsalze zuzugeben. Geeignete Metallsalze sind z. B. Formiate, Carbonate, Halogenide, Sulfate, Bu- tyrate, Valeriate, Capronate, Acetate, Lactate, Glykolate, Tartrate, Citrate, Gluconate, Pro- pionate, Phosphate und Phosphonate von Alkalimetallen, wie Kalium, Natrium oder Lithium, Erdalkalimetallen, wie Magnesium, Calcium, Strontium oder Barium, oder von Aluminium, Mangan, Eisen, Kobalt, Kupfer oder Zink, wobei Natriumacetat, Lithiumbromid, Calciumbro- mid, Calciumgluconat, Zinkchlorid, Zinksulfat, Magnesiumchlorid, Magnesiumsulfat, Ammo- niumcarbonat, -Chlorid und -acetat bevorzugt sind. Diese Salze sind vorzugsweise in einer Menge von 0,03 bis 65, insbesondere von 1 bis 40, mmol bezogen auf 100 g des gesamten Mittels, enthalten.For the coloring result it can be advantageous to add ammonium or metal salts to the agents. Suitable metal salts are e.g. B. formates, carbonates, halides, sulfates, butyrates, valerates, capronates, acetates, lactates, glycolates, tartrates, citrates, gluconates, propionates, phosphates and phosphonates of alkali metals, such as potassium, sodium or lithium, alkaline earth metals, such as Magnesium, calcium, strontium or barium, or of aluminum, manganese, iron, cobalt, copper or zinc, whereby sodium acetate, lithium bromide, calcium bromide, calcium gluconate, zinc chloride, zinc sulfate, magnesium chloride, magnesium sulfate, ammonium carbonate, chloride and acetate are preferred. These salts are preferably present in an amount of 0.03 to 65, in particular 1 to 40, mmol based on 100 g of the total composition.
Ein weiterer Gegenstand der vorliegenden Erfindung ist ein Verfahren zum Färben von keratinhaltigen Fasern, insbesondere menschlichen Haaren, worin ein erfindungsgemäßes Färbemittel, enthaltend übliche kosmetische Inhaltsstoffe, auf die keratinhaltigen Fasern aufgebracht, einige Zeit, üblicherweise ca. 30 Minuten, auf der Faser belassen und anschließend wieder ausgespült oder mit einem Shampoo ausgewaschen wird.Another object of the present invention is a process for dyeing keratin-containing fibers, in particular human hair, in which a colorant according to the invention, containing customary cosmetic ingredients, is applied to the keratin-containing fibers, left on the fiber for some time, usually about 30 minutes, and then rinsed out again or washed out with a shampoo.
Die oxidative Entwicklung der Färbung kann grundsätzlich mit Luftsauerstoff erfolgen. Bevorzugt wird jedoch ein chemisches Oxidationsmittel eingesetzt, besonders dann, wenn neben der Färbung ein Aufhelleffekt an menschlichem Haar gewünscht ist. Als Oxidationsmittel kommen Persulfate, Chlorite und insbesondere Wasserstoffperoxid oder dessen Anlagerungsprodukte an Harnstoff, Melamin sowie Natriumborat in Frage. Weiterhin ist es möglich, die Oxidation mit Hilfe von Enzymen durchzuführen. Dabei können die Enzyme zur Übertragung von Luftsauerstoff auf die Entwicklerkomponente oder zur Verstärkung der Wirkung geringer Mengen vorhandener Oxidationsmittel dienen. Ein Beispiel für ein enzymatisches Verfahren stellt das Vorgehen dar, die Wirkung geringer Mengen (z.B. 1 % und weniger, bezogen auf das gesamte Mittel) Wasserstoffperoxid durch Peroxidasen zu verstärken.In principle, the oxidative development of the coloring can take place with atmospheric oxygen. However, a chemical oxidizing agent is preferably used, especially if, in addition to the coloring, a lightening effect on human hair is desired. Persulfates, chlorites and in particular hydrogen peroxide or its adducts with urea, melamine and sodium borate are suitable as oxidizing agents. It is also possible to carry out the oxidation with the aid of enzymes. The enzymes can be used to transfer atmospheric oxygen to the developer component or to enhance the effect of small amounts of oxidizing agents present. An example of an enzymatic Process represents the procedure to increase the effect of small amounts (eg 1% and less, based on the total agent) of hydrogen peroxide by peroxidases.
Zweckmäßigerweise wird die Zubereitung des Oxidationsmittels unmittelbar vor dem Haa- refärben mit der Zubereitung aus den Oxidationsfarbstoffvorprodukten vermischt. Das dabei entstehende gebrauchsfertige Haarfärbepräparat sollte bevorzugt einen pH-Wert im Bereich zwischen 2 und 11 , vorzugsweise zwischen 5 und 10 aufweisen. Besonders bevorzugt ist die Anwendung der Haarmittel in einem schwach alkalischen Milieu. Die Anwendungstemperaturen können in einem Bereich zwischen 15 und 40 °C liegen. Nach einer Einwirkungszeit von ca. 30 Minuten wird das Mittel durch Ausspülen von dem zu färbenden Haar entfernt. Das Nachwaschen mit einem Shampoo entfällt, wenn ein stark tensidhaltiger Träger, z.B. ein Färbeshampoo, verwendet wurde.The preparation of the oxidizing agent is expediently mixed with the preparation from the oxidation dye precursors immediately before hair dyeing. The resulting ready-to-use hair dye preparation should preferably have a pH in the range between 2 and 11, preferably between 5 and 10. It is particularly preferred to use the hair products in a weakly alkaline environment. The application temperatures can range between 15 and 40 ° C. After an exposure time of approx. 30 minutes, the agent is removed from the hair to be colored by rinsing. Washing with a shampoo is not necessary if a carrier with a high tenside content, e.g. a coloring shampoo was used.
Noch ein weiterer Gegenstand der vorliegenden Erfindung betrifft die Verwendung von Verbindungen der Formel (I) zum Färben von keratinhaltigen Fasern.Yet another object of the present invention relates to the use of compounds of the formula (I) for dyeing fibers containing keratin.
Die nachfolgenden Beispiele sollen den Erfindungsgegenstand näher erläutern. The following examples are intended to explain the subject of the invention in more detail.
B e i s p i e l eB e i s p i e l e
Hersteilungsbeispiel 1Preparation Example 1
Stufe 1 : (4-Nitro-1 ,3-dimethylpyrazol-5-yl)-(2-((4-nitro-1 ,3-dimethylpyrazol-5-yl)amino)ethyl)-amir Zu einer Mischung aus 4,4 g (0,025 Mol) 5-Chlor-1 ,3-dimethyl-4-nitropyrazol, 1 ,7 g (0,125 Mol) K2CO3 und 0,1 g Cu-Pulver in 100 ml 1-Butanol wurde bei 80°C eine Lösung von 0,75 g (0,0125 Mol) 1 ,2-Diaminoethan in 25 ml 1-Butanol zugetropft. Nach 13 Stunden Kochen am Rückfluß wurde die heiße Lösung abfiltriert, nach dem Abkühlen wurde das Produkt abgesaugt. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 237°C erhaltenStep 1: (4-nitro-1,3-dimethylpyrazol-5-yl) - (2 - ((4-nitro-1,3-dimethylpyrazol-5-yl) amino) ethyl) -amir To a mixture of 4, 4 g (0.025 mol) of 5-chloro-1, 3-dimethyl-4-nitropyrazole, 1.7 g (0.125 mol) of K 2 CO 3 and 0.1 g of Cu powder in 100 ml of 1-butanol were at 80 ° C. A solution of 0.75 g (0.0125 mol) of 1,2-diaminoethane in 25 ml of 1-butanol was added dropwise. After refluxing for 13 hours, the hot solution was filtered off, after cooling the product was filtered off with suction. Yellow crystals with a melting point of 237 ° C. were obtained
Stufe 2:Level 2:
Das Produkt aus Stufe 1 wurde in 200 ml Ethanol und 0,1 g Pd/C bei 78°C und 25 atü hydriert. Nach Beendigung der H2-Aufnahme wurde der Katalysator abfiltriert. Die Lösung wurde mit verdünnter HCI angesäuert und zur Trockene eingedampft. Es wurde (4-Amino- 1 ,3-dimethylpyrazol-5-yl)-(2-((4-amino-1 ,3-dimethylpyrazol-5-yl)amino)ethyl)-amin x 4HCI in Form brauner Kristalle mit einem Schmelzpunkt von 220°C erhalten.The product from stage 1 was hydrogenated in 200 ml of ethanol and 0.1 g of Pd / C at 78 ° C. and 25 atm. After the H 2 uptake had ended, the catalyst was filtered off. The solution was acidified with dilute HCl and evaporated to dryness. There was (4-amino-1, 3-dimethylpyrazol-5-yl) - (2 - ((4-amino-1, 3-dimethylpyrazol-5-yl) amino) ethyl) amine x 4HCI in the form of brown crystals with obtained a melting point of 220 ° C.
Herstellungsbeispiel 2Production Example 2
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 1 wurde wiederholt, wobei anstelle von 1 ,2-Diami- noethan 1,1 g (0,0125 Mol) Piperazin eingesetzt wurden.Stage 1: Stage 1 from preparation example 1 was repeated, using 1.1 g (0.0125 mol) of piperazine instead of 1,2-diaminoethane.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 1. Es wurde 1 ,4-Bis-(1 ,3-dimethyl-4-nitro- pyrazol-5-yl)-piperazin x 4 HCI in Form orangefarbener Kristalle mit einem Schmelzpunkt über 206°C erhalten (Zersetzung).Stage 2: analogous to stage 2 from preparation example 1. 1,4-bis- (1,3-dimethyl-4-nitro-pyrazol-5-yl) -piperazine x 4 HCl was obtained in the form of orange crystals with a melting point above 206 ° C obtained (decomposition).
Herstellungsbeispiel 3Production Example 3
Stufe 1 : Eine Mischung aus 7 g (0,04 Mol) 5-Chlor-1 ,3-dimethyl-4-nitropyrazol, 10,3 g (0,08 Mol) 1-(2-Aminoethyl)-piperidin und 4 g (0,048 Mol) NaHCO3 in 60 ml Dimethylsulfoxid wurde 4 Stunden bei 90°C gerührt. Die Reaktionsmischung wurde auf 500 g Eis gegossen und der Niederschlag wurde abgesaugt. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 124°C erhalten. Stufe 2: 9 g des in Stufe 1 erhaltenen Produktes wurden in 400 ml Ethanol mit 0,6 g Pd/C bei Raumtemperatur und 1 atü hydriert. Nach Beendigung der H2-Aufnahme wurde der Katalysator abfiltriert. Die Lösung wurde mit verdünnter HCI angesäuert und zur Trockene eingedampft. Es wurde (4-Amino-1,3-dimethylpyrazol-5-yl)-(2-piperidyethyl)amin in Form beigefarbener Kristalle mit eine Schmelzpunkt von 123°C (Zersetzung) erhalten.Step 1: A mixture of 7 g (0.04 mol) of 5-chloro-1, 3-dimethyl-4-nitropyrazole, 10.3 g (0.08 mol) of 1- (2-aminoethyl) piperidine and 4 g (0.048 mol) NaHCO 3 in 60 ml dimethyl sulfoxide was stirred at 90 ° C for 4 hours. The reaction mixture was poured onto 500 g of ice and the precipitate was filtered off with suction. Yellow crystals with a melting point of 124 ° C. were obtained. Stage 2: 9 g of the product obtained in stage 1 were hydrogenated in 400 ml of ethanol with 0.6 g of Pd / C at room temperature and 1 atm. After the H 2 uptake had ended, the catalyst was filtered off. The solution was acidified with dilute HCl and evaporated to dryness. (4-Amino-1,3-dimethylpyrazol-5-yl) - (2-piperidyethyl) amine was obtained in the form of beige crystals with a melting point of 123 ° C. (decomposition).
Herstellungsbeispiel 4Production Example 4
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 10,4 g (0,08 Mol) N-(2-Aminoethyl)-morpholin eingesetzt wurden. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 112 - 114°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 10.4 g (0.08 mol) of N- (2-aminoethyl) morpholine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 112-114 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (4-Amino-1 ,3-dimethylpyra- zol-5-yl)-(2-morpholin-4-yl-ethyl)-amin x 3HCI in Form gelber Kristalle mit einem Schmelzpunkt von 105°C erhalten.Step 2: analogous to step 2 from preparation example 3. It was (4-amino-1, 3-dimethylpyrazol-5-yl) - (2-morpholin-4-yl-ethyl) amine x 3HCI in the form of yellow crystals with obtained a melting point of 105 ° C.
Herstellungsbeispiel 5Production Example 5
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 11,5 g (0,08 Mol) N-(3-Aminopropyl)-morpholin eingesetzt wurden. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 87 - 89°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 11.5 g (0.08 mol) of N- (3-aminopropyl) morpholine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 87-89 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (4-Amino-1 ,3-dimethylpyra- zol-5-yl)-3-morpholin-4-yl-propyl)-amin x 3HCI in Form gelber Kristalle mit einem Schmelzpunkt von 104°C erhalten.Step 2: analogous to step 2 from preparation example 3. It was (4-amino-1, 3-dimethylpyrazol-5-yl) -3-morpholin-4-yl-propyl) amine x 3HCI in the form of yellow crystals with a Obtained melting point of 104 ° C.
Herstellungsbeispiel 6Production Example 6
Stufe 1 : Zu einer Lösung aus 5 g (0,028 Mol) 5-Hydrazino-1 ,3-dimethyl-4-nitro-1 H-pyra- zol und 4,68 g (0,028 Mol) Tetramethoxypropan in 80 ml Ethanol wurden 19,8 ml 10-%ige HCI gegeben. Es wurde 2 Stunden unter Rückfluß gekocht, anschließend wurden 3 g (0,028 Mol) Na2CO3 in 10 ml H2O zugegeben und die Lösung wurde zur Trockene eingedampft. Der Rückstand wurde mit Ethanol extrahiert. Nach dem Einengen wurde der Rückstand aus EtOH umkristallisiert. Es wurden hell orangefarbene Kristalle mit einem Schmelzpunkt von 75°C erhalten.Step 1: To a solution of 5 g (0.028 mol) of 5-hydrazino-1, 3-dimethyl-4-nitro-1H-pyrazole and 4.68 g (0.028 mol) of tetramethoxypropane in 80 ml of ethanol were 19. Given 8 ml of 10% HCI. The mixture was boiled under reflux for 2 hours, then 3 g (0.028 mol) of Na 2 CO 3 in 10 ml of H 2 O were added and the solution became dry evaporated. The residue was extracted with ethanol. After concentration, the residue was recrystallized from EtOH. Bright orange crystals with a melting point of 75 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (1,3-Dimethyl-5-pyrazolyl- pyrazo-4-amin x 3HCI in Form orangefarbener Kristalle und einem Schmelzpunkt > 150°C (Zersetzung) erhalten.Stage 2: analogous to stage 2 from preparation example 3. This gave (1,3-dimethyl-5-pyrazolyl-pyrazo-4-amine x 3HCI in the form of orange crystals and a melting point> 150 ° C. (decomposition).
Herstellungsbeispiel 7Production Example 7
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 10,09 g (0,08 Mol) 1-(3-Aminopropyl)-imidazol eingesetzt wurden. Es wurde ein gelbes Öl erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 10.09 g (0.08 mol) of 1- (3-aminopropyl) imidazole instead of 1- (2-aminoethyl) piperidine. A yellow oil was obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (4-Amino-1,3-dimethylpyra- zol-5-yl)-(3-imidazolylpropyl)-amin x 3HCI in Form eines braunen Öls erhalten.Step 2: analogous to step 2 from preparation example 3. (4-Amino-1,3-dimethylpyrazol-5-yl) - (3-imidazolylpropyl) amine x 3HCI was obtained in the form of a brown oil.
Herstellungsbeispiel 8Production Example 8
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 12,7 g (0,08 Mol) 2-Amino-5-(diethylamino)pentan eingesetzt wurden. Es wurde ein gelbes Öl erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 12.7 g (0.08 mol) of 2-amino-5- (diethylamino) pentane instead of 1- (2-aminoethyl) piperidine. A yellow oil was obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (4-Amino-((1 ,3-dimethyl-4- aminopyrazol-5-yl)-amino)pentyl)-diethylamin x 3HCI in Form eines braunen Öls erhalten. Step 2: analogous to step 2 from preparation example 3. (4-Amino - ((1, 3-dimethyl-4-aminopyrazol-5-yl) -amino) pentyl) -diethylamine x 3HCI was obtained in the form of a brown oil.
Herstellungsbeispiel 9Production Example 9
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 5,9 g (0,08 Mol) Glycinamid eingesetzt wurden. Es wurden orangefarbene Kristalle mit einem Schmelzpunkt über 250°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 5.9 g (0.08 mol) of glycinamide instead of 1- (2-aminoethyl) piperidine. Orange crystals with a melting point above 250 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde 2-((4-Aιmino-1 ,3- dimethylpyrazol-5-yl)-amino)-acetamid x 2HCI in Form eines beigefarbenen Pulvers mit einem Schmelzpunkt von 220°C (Zersetzung) erhalten.Step 2: analogous to step 2 from preparation example 3. 2 - ((4-Aιmino-1, 3-dimethylpyrazol-5-yl) -amino) -acetamide x 2HCI in the form of a beige powder with a melting point of 220 ° C. ( Decomposition).
Herstellungsbeispiel 10Production Example 10
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 6,8 g (0,08 Mol) Cyclopentylamin eingesetzt wurden. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 76 - 80°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 6.8 g (0.08 mol) of cyclopentylamine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 76-80 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde 4-Amino-1,3-dimethylpyra- zol-5-yl-cyclopentylamin x 2HCI in Form beigefarbenen Pulvers mit einem Schmelzpunkt von 147°C erhalten.Step 2: analogous to step 2 from preparation example 3. 4-Amino-1,3-dimethylpyrazol-5-yl-cyclopentylamine x 2HCI was obtained in the form of beige powder with a melting point of 147 ° C.
Herstellungsbeispiel 11Production Example 11
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1 -(2- Aminoethyl)-piperidin 10,3 g (0,08 Mol) 1-(2-Aminoethyl)-piperazin eingesetzt wurden. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 124°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 10.3 g (0.08 mol) of 1- (2-aminoethyl) piperazine instead of 1 - (2-aminoethyl) piperidine. Yellow crystals with a melting point of 124 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (1 ,3-dimethyl-4-amino-5- yl)-(2-piperazinylethylamin) x 4HCI in Form brauner Kristalle mit einem Schmelzpunkt ab 108°C (Zersetzung) erhalten. Herstellungsbeispiel 12Stage 2: analogous to stage 2 from preparation example 3. (1, 3-dimethyl-4-amino-5-yl) - (2-piperazinylethylamine) x 4HCI was obtained in the form of brown crystals with a melting point above 108 ° C. (decomposition) , Production Example 12
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 8,3 g (0,08 Mol) 3-Ethoxypropylamin eingesetzt wurden. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 44°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, using 8.3 g (0.08 mol) of 3-ethoxypropylamine instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 44 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde 4-Amino-1,3-dimethylpyra- zol-5-yl)-(3-ethoxypropyl)amin x 3HCI in Form orangefarbener hygroskopischer Kristalle erhalten.Stage 2: analogous to stage 2 from preparation example 3. 4-Amino-1,3-dimethylpyrazol-5-yl) - (3-ethoxypropyl) amine x 3HCI was obtained in the form of orange-colored hygroscopic crystals.
Herstellungsbeispiel 13Production Example 13
Stufe 1 : Stufe 1 aus Herstellungsbeispiel 3 wurde wiederholt, wobei anstelle von 1-(2- Aminoethyl)-piperidin 9,7 g (0,08 Mol) 2-Phenylethylamin eingesetzt wurde. Es wurden gelbe Kristalle mit einem Schmelzpunkt von 99 - 101°C erhalten.Step 1: Step 1 from preparation example 3 was repeated, 9.7 g (0.08 mol) of 2-phenylethylamine being used instead of 1- (2-aminoethyl) piperidine. Yellow crystals with a melting point of 99-101 ° C. were obtained.
Stufe 2: analog Stufe 2 aus Herstellungsbeispiel 3. Es wurde (4-Amino-1,3-dimethylpyra- zol-5-yl)-(2-phenylethyl)amin x 2HCI in Form graublauer Kristalle mit einem Schmelzpunkt von 85 - 90°C erhalten.Stage 2: analogous to stage 2 from preparation example 3. It became (4-amino-1,3-dimethylpyrazol-5-yl) - (2-phenylethyl) amine x 2HCI in the form of gray-blue crystals with a melting point of 85-90 ° C received.
Herstellungsbeispiel 14Production Example 14
Stufe 1 : 7,9g (0,045Mol) 5-Chlor-1 ,3-dimethyl-4-nitropyrazol wurden in 60ml Dimethylsulfoxid unter Rühren in einer Stickstoffatmosphäre vorgelegt. Eine Lösung aus 5g (0,045Mol) Glycinamid-hydrochlorid, 7,5g Kaliumcarbonat (0,054Mol) und 20ml Wasser wurde zugegeben. Anschließend wurde für 22h bei 70°C gerührt. Der Reaktionsansatz wurde abgekühlt und auf Eis gegossen. Die gelb/orange Fällung wurde abgesaugt, mit Wasser gewaschen, in 50ml kaltem Dimethylformamid aufgeschlämmt, erneut abgesaugt und mit Wasser gewaschen. Das Reaktionsprodukt wurde bei 50°C im Vakuum getrocknet und wies einen Schmelzpunkt oberhalb von 250°C auf.Step 1: 7.9 g (0.045 mol) of 5-chloro-1,3-dimethyl-4-nitropyrazole were placed in 60 ml of dimethyl sulfoxide with stirring in a nitrogen atmosphere. A solution of 5 g (0.045 mol) glycinamide hydrochloride, 7.5 g potassium carbonate (0.054 mol) and 20 ml water was added. The mixture was then stirred at 70 ° C. for 22 h. The reaction mixture was cooled and poured onto ice. The yellow / orange precipitate was suction filtered, washed with water, slurried in 50 ml of cold dimethylformamide, suction filtered again and washed with water. The reaction product was dried at 50 ° C in a vacuum and had a melting point above 250 ° C.
Stufe 2: 3g (0,014Mol) 2-((1',3'-Dimethyl-4'-nitropyrazol-5'-yl)amino)-acetamid wurden in 150ml Ethanol und 50ml Wasser mit 0,65g eines Pd-Katalysators (5%Pd auf C) bei Raumtemperatur hydriert. Anschließend wurden 20ml einer 20%igen HCI-Lösung zugegeben, die Reaktionsmischung unter Stickstoff filtriert und bis zur Trockene eingeengt. Es wurde 2-((1',3'-Dimethyl-4,-aminopyrazol-5'-yl)amino)-acetamid-dihydrochlorid erhalten, das sich bei 220°C zersetzte.Step 2: 3 g (0.014 mol) of 2 - ((1 ', 3'-dimethyl-4'-nitropyrazol-5'-yl) amino) -acetamide were dissolved in 150 ml of ethanol and 50 ml of water with 0.65 g of a Pd catalyst ( 5% Pd on C) at Room temperature hydrogenated. 20 ml of a 20% HCl solution were then added, the reaction mixture was filtered under nitrogen and evaporated to dryness. 2 - ((1 ', 3'-Dimethyl-4 , -aminopyrazol-5'-yl) amino) -acetamide dihydrochloride was obtained, which decomposed at 220 ° C.
Herstellungsbeispiel 15Production Example 15
Stufe 1 : 8,0g (0,046Mol) 5-Chlor-1 ,3-dimethyl-4-nitropyrazol, 3,6g (0,042Mol) Cyclopentylamin und 4,4g (0,052Mol) Natriumhydrogencarbonat wurden in 50ml Dimethylsulfoxid für 22h bei 75 bis 80°C gerührt. Der Reaktionsansatz wurde abgekühlt und auf Eis gegossen. Die gelbe Fällung wurde abgesaugt und aus 500ml Wasser bei 50 bis 60°C umkristallisiert. Das Reaktionsprodukt wurde bei 50°C im Vakuum getrocknet und wies einen Schmelzpunkt von 76 bis 80°C mit Zersetzung auf.Step 1: 8.0 g (0.046 mol) of 5-chloro-1, 3-dimethyl-4-nitropyrazole, 3.6 g (0.042 mol) of cyclopentylamine and 4.4 g (0.052 mol) of sodium hydrogen carbonate were in 50 ml of dimethyl sulfoxide for 22 h at 75 to 80 ° C stirred. The reaction mixture was cooled and poured onto ice. The yellow precipitate was filtered off and recrystallized from 500 ml of water at 50 to 60 ° C. The reaction product was dried at 50 ° C in a vacuum and had a melting point of 76 to 80 ° C with decomposition.
Stufe 2: 6,1g (0,027Mol) (1 ,3-Dimethyl-4-nitropyrazol-5-yl)cyclopentylamin wurden in 75ml Ethanol und 25ml Wasser mit 0,53g eines Pd-Katalysators (5%Pd auf C) bei 50°C und 20bar für 24h im Autoklav hydriert. Anschließend wurden 20ml einer 20%igen HCI-Lösung zugegeben, die Reaktionsmischung unter Stickstoff filtriert und bis zur Trockene eingeengt. Es wurde (1 ,3-Dimethyl-4-aminopyrazol-5-yl)cyclopentylamin erhalten, das sich bei 147°C zersetzte. Step 2: 6.1g (0.027 mol) (1,3-dimethyl-4-nitropyrazol-5-yl) cyclopentylamine were dissolved in 75ml ethanol and 25ml water with 0.53g Pd catalyst (5% Pd on C) at 50 ° C and 20bar hydrogenated for 24h in an autoclave. 20 ml of a 20% HCl solution were then added, the reaction mixture was filtered under nitrogen and evaporated to dryness. (1, 3-Dimethyl-4-aminopyrazol-5-yl) cyclopentylamine was obtained, which decomposed at 147 ° C.
Ausfärbungsbeispiele 1 bis 30Coloring examples 1 to 30
Es wurde zunächst eine Cremebasis folgender Zusammensetzung hergestellt [alle Angaben sind, soweit nicht anders vermerkt, in g]:First, a cream base of the following composition was produced [unless otherwise stated, all data are in g]:
Taigfettalkohol 17,0Taig fatty alcohol 17.0
Lorol®techn. 4,0Lorol ® techn. 4.0
Texapon®N 282 40,0Texapon ® N 28 2 40.0
Dehyton^K 25,0Dehyton ^ K 25.0
Eumulgin®B 2 1 ,5 destilliertes Wasser 12,5Eumulgin ® B 2 1, 5 distilled water 12.5
C12-ιs-Fettalkohol (Cognis)C 12 ιs fatty alcohol (Cognis)
Natriumlaurylethersulfat (ca. 28 % Aktivsubstanz; INCI-Bezeichnung: SodiumSodium lauryl ether sulfate (approx. 28% active substance; INCI name: Sodium
Laureth Sulfate) (Cognis)Laureth Sulfate) (Cognis)
Fettsäureamid-Derivat mit Betainstruktur der FormelFatty acid amide derivative with betaine structure of the formula
R-CONH(CH2)3N+(CH3)2CH2COO- (ca. 30 % Aktivsubstanz; INCI- Bezeichnung Co- coamidopropyl Betaine) (Cognis)R-CONH (CH 2 ) 3 N + (CH 3 ) 2 CH 2 COO- (approx. 30% active substance; INCI name Co-coamidopropyl betaine) (Cognis)
Cetylstearylalkohol mit ca. 20 EO-Einheiten (INCI-Bezeichnung: Ceteareth-Cetylstearyl alcohol with approx. 20 EO units (INCI name: Ceteareth-
20) (Cognis)20) (Cognis)
Auf Basis dieser Creme wurde dann folgende Haarfärbecremeemulsion hergestellt:The following hair dye cream emulsion was then produced on the basis of this cream:
Cremebasis 50,0Cream base 50.0
Entwicklerkomponente 7,5 mmolDeveloper component 7.5 mmol
Kupplerkomponente 7,5 mmolCoupler component 7.5 mmol
Na2SO3 (Inhibitor) 1 ,0Na 2 SO 3 (inhibitor) 1.0
(NH4)2SO4 1 ,0 konz. Ammoniaklösung ad pH 10(NH 4 ) 2 SO 4 1.0 conc. Ammonia solution ad pH 10
Wasser ad 100Water ad 100
Die Bestandteile wurden der Reihe nach miteinander vermischt. Nach Zugabe der Oxidati- onsfarbstoffvorprodukte und des Inhibitors wurde zunächst mit konzentrierter Ammoniaklö- sung der pH-Wert der Emulsion auf 10 eingestellt, dann wurde mit Wasser auf 100 g aufgefüllt.The ingredients were mixed together in order. After the oxidation dye precursors and the inhibitor had been added, concentrated ammonia solution, the pH of the emulsion was adjusted to 10, then the mixture was made up to 100 g with water.
Die oxidative Entwicklung der Färbung wurde mit Luftsauerstoff oder 1 %iger Wasserstoffperoxidlösung als Oxidationslösung durchgeführt. Hierzu wurde die Emulsion für die Luftoxidation so belassen, für die Oxdiation mit H2O2 wurden 100 g der Emulsion mit 50 g Wasserstoffperoxidlösung (1 %ig) versetzt und vermischt.The oxidative development of the color was carried out with atmospheric oxygen or 1% hydrogen peroxide solution as the oxidation solution. For this purpose, the emulsion for air oxidation was left as it was, for oxidation with H 2 O 2 , 100 g of the emulsion were mixed with 50 g of hydrogen peroxide solution (1%) and mixed.
Die resultierende Anwendungszubereitung wurde jeweils auf ca. 5 cm lange Strähnen standardisierten, zu 90 % ergrauten, aber nicht besonders vorbehandelten Menschenhaars aufgetragen und dort 30 Minuten bei 32 °C belassen. Nach Beendigung des Färbeprozesses wurde das Haar gespült, mit einem üblichen Haarwaschmittel gewaschen und anschließend getrocknet. Für die Ausfärbungen wurden folgende Entwickler- und Kuppler-Komponenten verwendet:The resulting application preparation was applied in each case to strands of approximately 5 cm long, standardized, 90% gray, but not specially pretreated human hair and left there at 32 ° C. for 30 minutes. After the dyeing process was completed, the hair was rinsed, washed with a conventional shampoo and then dried. The following developer and coupler components were used for the colorations:
Entwickler-Komponenten (erfindungsgemäß)Developer components (according to the invention)
E1 (1 ,3-Dimethyl-4-amino-pyrazol-5-yl)-(2-((1 ',3'-dimethyl-4'-amino-pyrazol-5'- yl)amino)ethyl)-amin x 4HCIE1 (1, 3-Dimethyl-4-aminopyrazol-5-yl) - (2 - ((1 ', 3'-dimethyl-4'-aminopyrazol-5'-yl) amino) ethyl) amine x 4HCI
E2 1 ,4-Bis-(1 ',3'-dimethyl-4'-aminopyrazol-5-yl)-piperazin x 4 HCIE2 1, 4-bis (1 ', 3'-dimethyl-4'-aminopyrazol-5-yl) piperazine x 4 HCl
E3 (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-piperazinylethyl)-aminE3 (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2-piperazinylethyl) amine
E4 (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-(morpholin-4'-yl)ethyl)-amin x 3HCIE4 (1, 3-Dimethyl-4-aminopyrazol-5-yl) - (2- (morpholin-4'-yl) ethyl) amine x 3HCI
E5 (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(3-(morpholin-4'-yl)propyl)-amin x 3HCIE5 (1, 3-Dimethyl-4-aminopyrazol-5-yl) - (3- (morpholin-4'-yl) propyl) amine x 3HCI
E6 1 -(1 ',3'-Dimethyl-4'-amino-pyrazol-5'-yl)-pyrazol x 3HCIE6 1 - (1 ', 3'-Dimethyl-4'-aminopyrazol-5'-yl) pyrazole x 3HCI
E7 (1 ,3-Dimethyl-4-amino-pyrazol-5-yl)-(3-imidazolylpropyl)-amin x 3HCIE7 (1, 3-Dimethyl-4-aminopyrazol-5-yl) - (3-imidazolylpropyl) amine x 3HCI
E8 (4-Amino-((1 ,3-dimethyl-4-aminopyrazol-5-yl)-amino)pentyl)-diethylamin x 3HCIE8 (4-amino - ((1,3-dimethyl-4-aminopyrazol-5-yl) amino) pentyl) diethylamine x 3HCI
E9 2-((1',3'-Dimethyl-4'-amino-pyrazol-5'-yl)-amino)-acetamid x 2HCIE9 2 - ((1 ', 3'-Dimethyl-4'-aminopyrazol-5'-yl) amino) acetamide x 2HCI
E10 (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(cyclopentyl)-amin x 2HCIE10 (1, 3-dimethyl-4-aminopyrazol-5-yl) - (cyclopentyl) amine x 2HCI
E11 (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-piperazinylethyl)-amin x 4HCI x 2H2OE11 (1, 3-Dimethyl-4-aminopyrazol-5-yl) - (2-piperazinylethyl) amine x 4HCI x 2H 2 O
E12 (1 ,3-Dimethyl-4-amino-pyrazol-5-yl)-(3-ethoxypropyl)amin x 2HCIE12 (1, 3-Dimethyl-4-aminopyrazol-5-yl) - (3-ethoxypropyl) amine x 2HCI
E13 (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-phenylethyl)-amin x 2HCIE13 (1,3-dimethyl-4-aminopyrazol-5-yl) - (2-phenylethyl) amine x 2HCI
Kuppler-Komponenten KCoupler components K
K1 2-Methyl-5-aminophenolK1 2-methyl-5-aminophenol
K2 2-Chlor-6-methyl-3-aminophenol K3 1-NaphtholK2 2-chloro-6-methyl-3-aminophenol K3 1-naphthol
K4 1 ,3-Bis-(2',4'-diamino-phenoxy)propanK4 1,3-bis (2 ', 4'-diamino-phenoxy) propane
K5 m-AminophenolK5 m-aminophenol
K6 2,4-DiaminophenoxyethanolK6 2,4-diaminophenoxyethanol
K7 Resorcin K7 resorcinol
wurden folgende Ausfärbungen gefunden:the following colors were found:
Figure imgf000027_0001
Ausfärbungsbeispiel 31
Figure imgf000027_0001
Coloring example 31
Es wurde die folgende Färbecreme und die folgende Oxidationsmittelzubereitung hergestellt:The following coloring cream and the following oxidizing agent preparation were produced:
Figure imgf000028_0001
Figure imgf000028_0001
C12-ι -Fettalkohol mit ca. 2-EO-Einheiten (INCI-Bezeichnung: Laureth-2) (Cognis)C 12 ι fatty alcohol with approx. 2 EO units (INCI name: Laureth-2) (Cognis)
C12-ι8-Fettalkohol (INCI-Bezeichnung: Coconut Alcohol) (Cognis)C ι 12- 8 fatty alcohol (INCI name: Coconut Alcohol) (Cognis)
Ölsäure (INCI-Bezeichnung: Oleic Acid) (Cognis)Oleic acid (INCI name: Oleic Acid) (Cognis)
Laurylethersulfat-Natrium-Salz (ca. 26,5 bis 27,5% Aktivsubstanzgehalt; INCI- Bezeichnung: Sodium Laureth Sulfate) (Cognis)Lauryl ether sulfate sodium salt (approx. 26.5 to 27.5% active substance content; INCI name: Sodium Laureth Sulfate) (Cognis)
Weizenproteinhydrolysat (ca. 40% Festkörper; INCI-Bezeichnung: Aqua (Water), Hydrolyzed Wheat Protein, Sodium Benzoate, Phenoxyethanol, Methylparaben, Propylparaben) (Cognis)Wheat protein hydrolyzate (approx. 40% solids; INCI name: Aqua (Water), Hydrolyzed Wheat Protein, Sodium Benzoate, Phenoxyethanol, Methylparaben, Propylparaben) (Cognis)
1010
1-Hydroxyethan-1 ,1-diphosphonsäure (ca. 58 bis 61% Aktivsubstanz; INCI- Bezeichnung: Etidronic Acid, Aqua (Water)) (Cognis)
Figure imgf000029_0001
1-Hydroxyethane-1, 1-diphosphonic acid (approx. 58 to 61% active substance; INCI name: Etidronic Acid, Aqua (Water)) (Cognis)
Figure imgf000029_0001
11 Methacrylsäure(stearylalkohol+20-EO-ester)-Acrylsäure-Copolymer (ca. 30% Aktivsubstanz; INCI-Bezeichnung: Acrylates/Steareth-20 Methacrylate Copolymer) (Rohm & Haas)11 methacrylic acid (stearyl alcohol + 20-EO-ester) -acrylic acid copolymer (approx. 30% active substance; INCI name: Acrylates / Steareth-20 methacrylate copolymer) (Rohm & Haas)
12 Wasserstoffperoxid (ca. 50% Aktivsubstanzgehalt; INCI-Bezeichnung: Hydrogen Peroxide) (Degussa)12 hydrogen peroxide (approx. 50% active substance content; INCI name: hydrogen peroxide) (Degussa)
2g der Färbecreme wurden mit 2g der Oxidationsmittelzubereitung vermischt und auf 5 bis 6cm lange Haarsträhnen (Kerling, 80% grau) aufgetragen. Nach 30 min. Einwirkzeit bei 32°C wurde das Haar gespült, mit einem üblichen Haarwaschmittel ausgewaschen und anschließend getrocknet. Das Haar wies eine violette Färbung auf. 2 g of the coloring cream were mixed with 2 g of the oxidizing agent preparation and applied to 5 to 6 cm long strands of hair (Kerling, 80% gray). After 30 min. Exposure time at 32 ° C, the hair was rinsed, washed out with a normal shampoo and then dried. The hair was purple in color.
Ausfärbungsbeispiel 32Coloring example 32
Es wurde die folgende Färbecreme und die folgende Oxidationsmittelzubereitung hergestellt:The following coloring cream and the following oxidizing agent preparation were produced:
Figure imgf000030_0001
Figure imgf000030_0001
1313
C 6-i8-Fettalkohol (INCI-Bezeichnung: Cetearyl Alcohol) (Cognis) 14C 6 -i8 fatty alcohol (INCI name: Cetearyl Alcohol) (Cognis) 14
2-Octyldodecylalkohol (INCI-Bezeichnung: Octyldodecanol) (Cognis) 152-Octyldodecyl alcohol (INCI name: Octyldodecanol) (Cognis) 15
C16-i8-Fettalkohol mit ca.12-EO-Einheiten (INCI-Bezeichnung: Ceteareth-12) (Cognis) 16C 16 -i8 fatty alcohol with approx. 12 EO units (INCI name: Ceteareth-12) (Cognis) 16
Laurylmyristylethersulfat-Natrium-Salz (ca. 68 bis 73% Aktivsubstanzgehalt; INCI- Bezeichnung: Sodium Myreth Sulfate) (Cognis)Lauryl myristyl ether sulfate sodium salt (approx. 68 to 73% active substance content; INCI name: Sodium Myreth Sulfate) (Cognis)
1717
C12-16-Alkyl-1.4-glucosid (ca. 50 bis 53% Aktivsubstanzgehalt; INCI-Bezeichnung: Lauryl Glucoside) (Cognis) 18C 12-16 -alkyl-1,4-glucoside (approx. 50 to 53% active substance content; INCI name: Lauryl Glucoside) (Cognis) 18
Laurylalkohol-4.5-EO-Essigsäure-Natrium-Salz (mind. 21% Aktivsubstanzgehalt; INCI- Bezeichnung: Sodium Laureth-6 Carboxylate) (Chem-Y)Lauryl alcohol-4.5-EO-acetic acid sodium salt (at least 21% active substance content; INCI name: Sodium Laureth-6 carboxylate) (Chem-Y)
1919
Acrylsäure-Natrium-Salz-Acrylamidopropyltrimethylammoniumchlorid-Copolymer konserviert mit Phenonip (ca. 19 bis 21% Aktivsubstanzgehalt; INCI-Bezeichnung: Acrylamidopropyltrimonium Chloride/Acrylates Copolymer) (Stockhausen)Acrylic acid-sodium salt-acrylamidopropyltrimethylammonium chloride copolymer preserved with Phenonip (approx. 19 to 21% active substance content; INCI name: Acrylamidopropyltrimonium Chloride / Acrylates Copolymer) (Stockhausen)
Figure imgf000031_0001
Figure imgf000031_0001
20 Silicon Emulsion, nichtionogen (ca. 10%Aktivsubstanzgehalt; INCI-Bezeichnung: Dimethicone) (Dow Corning)20 silicone emulsion, non-ionic (approx. 10% active substance content; INCI name: Dimethicone) (Dow Corning)
2g der Färbecreme wurden mit 2g der Oxidationsmittelzubereitung vermischt und auf 5 bis 6cm lange Haarsträhnen (Kerling, 80% grau) aufgetragen. Nach 30 min. Einwirkzeit bei 32°C wurde das Haar gespült, mit einem üblichen Haarwaschmittel ausgewaschen und anschließend getrocknet. Das Haar wies eine braune Färbung auf. 2 g of the coloring cream were mixed with 2 g of the oxidizing agent preparation and applied to 5 to 6 cm long strands of hair (Kerling, 80% gray). After 30 min. Exposure time at 32 ° C, the hair was rinsed, washed out with a normal shampoo and then dried. The hair was brown in color.

Claims

P a t e n t a n s p r ü c h e Patent claims
1. Mittel, zum Färben von keratinhaltigen Fasern, enthaltend Oxidationsfarbstoffvorpro- dukte, dadurch gekennzeichnet, dass als Entwicklerkomponente mindestens eine Verbindung mit der allgemeinen Formel I enthalten ist1. Means for dyeing keratin-containing fibers containing oxidation dye precursors, characterized in that at least one compound of the general formula I is contained as developer component
Figure imgf000032_0001
in der
Figure imgf000032_0001
in the
R1 und R2 gleich oder verschieden sein können und für Wasserstoff, C1-4-Alkyl oder C1-4-Hydroxyalkyl stehen und R3 stehtR1 and R2 may be the same or different and represent hydrogen, C 1-4 alkyl or C 1-4 hydroxyalkyl and R3 represents
• für eine Gruppe mit der Formel II,• for a group with the formula II,
Figure imgf000032_0002
in der R4 für einen Piperazinylrest oder eine Gruppe -NR7(CH2)n-NR7 steht, in der R7 Wasserstoff oder C1-4-Alkyl und n eine ganze Zahl von 1 bis 4 sein können,
Figure imgf000032_0002
in which R4 represents a piperazinyl radical or a group -NR7 (CH 2 ) n -NR7, in which R7 is hydrogen or C 1-4 -alkyl and n can be an integer from 1 to 4,
R5 und R6 gleich oder verschieden sein können und Wasserstoff, C1- -Alkyl oder C-ι-4-Hydroxyalkyl bedeuten,R5 and R6 may be the same or different and are hydrogen, C 1 alkyl or C-ι mean -4 hydroxyalkyl,
für eine Gruppe °derfor a group ° the
• für eine Gruppe
Figure imgf000032_0003
in der R9 Wasserstoff, C1-4-Alkyl oder C1- -Hydroxyalkyl bedeutet,
• for a group
Figure imgf000032_0003
in which R9 is hydrogen, C 1-4 -alkyl or C 1- -hydroxyalkyl,
Y steht für eine direkte Bindung oder eine geradkettige oder verzweigte C1-5-Y stands for a direct bond or a straight-chain or branched C 1-5 -
Alkylengruppe und A steht für einen gesättigten oder ungesättigten, gegebenenfalls ein oder mehrere Heteroatome enthaltenden 5-, 6- oder 7-Ring, eine Gruppe -CO-NH2, eine C1- -Alkoxygruppe oder eine C1- -Dialkylaminogruppe, wobei A mit jedem beliebigen Kohlenstoffatom der Alkylengruppe Y verknüpft sein kann.Alkylene group and A stands for a saturated or unsaturated, optionally containing one or more heteroatoms 5-, 6- or 7-ring, a group -CO-NH 2 , a C 1- alkoxy group or a C 1- dialkylamino group, A with each any carbon atom of the alkylene group Y can be linked.
2. Mittel nach Anspruch 1 , dadurch gekennzeichnet, dass in der Formel I R3 für eine Gruppe mit der Formel II steht.2. Composition according to claim 1, characterized in that in the formula I R3 represents a group with the formula II.
3. Mittel nach Anspruch 2, dadurch gekennzeichnet, daß R1 und R6 sowie R2 und R5 jeweils gleich sind.3. Means according to claim 2, characterized in that R1 and R6 and R2 and R5 are each the same.
4. Mittel nach einem der Ansprüche 2 oder 3, dadurch gekennzeichnet, dass die Verbindung der Formel I ausgewählt ist aus (1 ,3-Dimethyl-4-amino-pyrazol-5-yl)-(2- ((1',3'-dimethyl-4'-amino-pyrazol-5,-yl)amino)ethyl)-amin und 1 ,4-Bis-(1',3'-dimethyl-4'- aminopyrazol-5'-yl)-piperazin oder deren Salzen.4. Composition according to one of claims 2 or 3, characterized in that the compound of formula I is selected from (1, 3-dimethyl-4-amino-pyrazol-5-yl) - (2- ((1 ', 3rd '-dimethyl-4'-aminopyrazol-5 , -yl) amino) ethyl) amine and 1,4-bis (1', 3'-dimethyl-4'-aminopyrazol-5'-yl) piperazine or their salts.
5. Mittel nach Anspruch 1 , dadurch gekennzeichnet, dass die Gruppe A steht für eine der Gruppen Piperidyl-, Morpholin-4-yl-, Imidazolyl-, Cyclopentyl-, Piperazinyl-, Pyrazolyl- oder Phenyl-.5. Composition according to claim 1, characterized in that the group A represents one of the groups piperidyl, morpholin-4-yl, imidazolyl, cyclopentyl, piperazinyl, pyrazolyl or phenyl.
6. Mittel nach Anspruch 1 oder 5, dadurch gekennzeichnet, dass die Gruppe Y steht für eine Ethylen- oder eine Propylengruppe.6. Composition according to claim 1 or 5, characterized in that the group Y represents an ethylene or a propylene group.
7. Mittel nach einem der Ansprüche 1 , 5 oder 6, dadurch gekennzeichnet, dass der Substituent -Y-A steht für einen 2-Piperidylethylrest, einen 2-(Morpholin-4- yl)ethylrest, einen 3-(Morpholin-4-yl)propylrest, einen 3-lmidazolylpropylrest, einen (N,N-Diethylamino)pentylrest, einen Cyclopentylrest, einen 2-Piperazinylethylrest, einen 2-Phenylethylrest oder einen 3-Ethoxypropylrest.7. Composition according to one of claims 1, 5 or 6, characterized in that the substituent -YA stands for a 2-piperidylethyl radical, a 2- (morpholin-4-yl) ethyl radical, a 3- (morpholin-4-yl) propyl, 3-imidazolylpropyl, (N, N-diethylamino) pentyl, cyclopentyl, 2-piperazinylethyl, 2-phenylethyl or 3-ethoxypropyl.
8. Mittel nach einem der Ansprüche 1 oder 5 bis 7, dadurch gekennzeichnet, dass die Verbindung mit der Formel I ausgewählt ist aus (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2- piperidylethyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-(morpholin-4'-yl)ethyl)- amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(3-(morpholin-4'-yl)propyl)-amin, 1 ,3-Dime- thyl-4-amino-5-pyrazolylpyrazol, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(3-imidazolylpro- pyl)-amin, N-(4-((1,,3'-Dimethyl-4*-aminopyrazol-5'-yl)-amino)pentyl)-N,N-diethyl-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(cyclopentyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol- 5-yl)-(2-piperazinylethyl)-amin, (1 ,3-Dimethyl-4-aminopyrazol-5-yl)-(2-phenylethyl)- amin, 2-((4'-Amino-1,,3'-dimethylpyrazol-5'-yl)-amino)-acetamid, (4-Amino-1 ,3-dime- thyl-pyrazol-5-yl)-(3-ethoxypropyl)-amin und deren physiologisch verträglichen Salzen sowie beliebigen Gemischen der voranstehenden.8. Agent according to one of claims 1 or 5 to 7, characterized in that the compound of formula I is selected from (1, 3-dimethyl-4-aminopyrazol-5-yl) - (2-piperidylethyl) amine, (1,3-Dimethyl-4-aminopyrazol-5-yl) - (2- (morpholin-4'-yl) ethyl) amine, (1,3-dimethyl-4-aminopyrazol-5-yl) - (3rd - (Morpholin-4'-yl) propyl) amine, 1,3-dimethyl-4-amino-5-pyrazolylpyrazole, (1,3-dimethyl-4-aminopyrazol-5-yl) - (3-imidazolylpro - propyl) amine, N- (4 - ((1, 3'-dimethyl-4 * -aminopyrazol-5'-yl) amino) pentyl) -N, N-diethyl-amine, (1,3-dimethyl-4-aminopyrazol-5-yl) - (cyclopentyl) amine, (1,3-dimethyl-4-aminopyrazol-5-yl) - (2-piperazinylethyl) amine, (1,3 dimethyl-4-aminopyrazole-5-yl) - (2-phenylethyl) - amine, 2 - ((4'-amino-1, 3'-dimethylpyrazol-5'-yl) amino) -acetamide, (4 -Amino-1, 3-dimethyl-pyrazol-5-yl) - (3-ethoxypropyl) amine and their physiologically tolerable salts and any mixtures of the foregoing.
9. Mittel nach einem der Ansprüche 1 bis 8, dadurch gekennzeichnet, dass die Verbindung mit der Formel I insgesamt in einer Menge von 0,005 bis 20 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-% enthalten ist.9. Composition according to one of claims 1 to 8, characterized in that the compound with the formula I is contained in total in an amount of 0.005 to 20 wt .-%, preferably 0.1 to 5 wt .-%.
10. Mittel nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, dass weitere Entwickler-Komponenten ausgewählt aus primären aromatischen Aminen mit einer weiteren, in para- oder ortho-Position befindlichen, freien oder substituierten Hydroxy- oder Aminogruppe, Diaminopyridinderivate, heterocyclische Hydrazone, 4-Aminopyra- zolderivate sowie 2,4,5,6-Tetraaminopyrimidin und dessen Derivate eingesetzt werden.10. Agent according to one of claims 1 to 9, characterized in that further developer components selected from primary aromatic amines with a further, in the para or ortho position, free or substituted hydroxy or amino group, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine and its derivatives are used.
11. Mittel nach Anspruch 10, dadurch gekennzeichnet, dass die weiteren Entwicklerkomponenten ausgewählt sind aus p-Phenylendiamin, p-Toluylendiamin, 2,4,5,6-Tetraaminopyrimidin, p-Aminophenol, N,N-Bis(2'-hydroxyethyl)-p-pheny- lendiamin, 2-(2',5'-Diaminophenyl)-ethanol, 2-(2',5'-Diaminophenoxy)-ethanol, 4- Amino-3-methylphenol, 2-Aminomethyl-4-aminophenol, 4-Amino-2- diethylaminomethylphenol, 2-Hydroxy-4,5,6-triaminopyrimidin, 2,4-Dihydroxy-5,6- diaminopyrimidin, 2,5,6-Triamino-4-hydroxypyrimidin und 1 ,3-N,N'-Bis(2'-hydroxy- ethyl)-N,N'-bis(4'-aminophenyl)-diamino-propan-2-ol enthalten sind.11. Agent according to claim 10, characterized in that the further developer components are selected from p-phenylenediamine, p-toluenediamine, 2,4,5,6-tetraaminopyrimidine, p-aminophenol, N, N-bis (2'-hydroxyethyl) -p-phenylenediamine, 2- (2 ', 5'-diaminophenyl) ethanol, 2- (2', 5'-diaminophenoxy) ethanol, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol , 4-amino-2-diethylaminomethylphenol, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, 2,5,6-triamino-4-hydroxypyrimidine and 1, 3-N , N'-bis (2'-hydroxyethyl) -N, N'-bis (4'-aminophenyl) diamino-propan-2-ol are contained.
12. Mittel nach einem der Ansprüche 1 bis 11 , dadurch gekennzeichnet, dass es mindestens eine Kuppler-Komponente enthält.12. Composition according to one of claims 1 to 11, characterized in that it contains at least one coupler component.
13. Mittel nach Anspruch 12, dadurch gekennzeichnet, dass die Kupplerkomponenten ausgewählt ist aus 1-Naphthol, 1,5-, 2,7- und 1 ,7-Dihydroxynaphthalin, 3-Aminophe- nol, 5-Amino-2-methylphenol, 2-Amino-3-hydroxypyridin, Resorcin, 4-Chlorresorcin, 2- Chlor-6-methyl-3-aminophenol, 2-Methylresorcin, 5-Methylresorcin, 2,5-Dimethylre- sorcin und 2,6-Dihydroxy-3,4-dimethylpyridin. 13. Composition according to claim 12, characterized in that the coupler component is selected from 1-naphthol, 1,5-, 2,7- and 1, 7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3, 4-dimethylpyridine.
14. Mittel nach einem der Ansprüche 1 bis 13, dadurch gekennzeichnet, dass die Entwickler- und Kupplerkomponenten jeweils in einer Menge von 0,005 bis 20 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, jeweils bezogen auf das gesamte Oxidationsfärbemittel, enthalten sind.14. Composition according to one of claims 1 to 13, characterized in that the developer and coupler components in each case in an amount of 0.005 to 20 wt .-%, preferably 0.1 to 5 wt .-%, each based on the entire oxidation colorant , are included.
15. Mittel nach einem der Ansprüche 1 bis 14, dadurch gekennzeichnet, dass weiterhin mindestens ein direktziehender Farbstoff enthalten ist.15. Agent according to one of claims 1 to 14, characterized in that it also contains at least one substantive dye.
16. Verfahren zum Färben von keratinhaltigen Fasern, insbesondere menschlichen Haaren, worin ein Färbemittel nach einem der Ansprüche 1 bis 15, enthaltend übliche kosmetische Inhaltsstoffe, auf die keratinhaltigen Fasern aufgebracht, einige Zeit, üblicherweise ca. 30 Minuten, auf der Faser belassen und anschließend wieder ausgespült oder mit einem Shampoo ausgewaschen wird.16. A process for dyeing keratin-containing fibers, in particular human hair, wherein a colorant as claimed in any one of claims 1 to 15, containing customary cosmetic ingredients, is applied to the keratin-containing fibers for some time, usually about 30 minutes, and then rinsed out again or washed out with a shampoo.
17. Verwendung von Verbindungen der Formel (I) zum Färben von keratinhaltigen Fasern. 17. Use of compounds of formula (I) for dyeing keratin fibers.
PCT/EP2001/008656 2000-08-02 2001-07-26 Agent for dyeing keratin containing fibers WO2002009662A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01980217A EP1304995A2 (en) 2000-08-02 2001-07-26 Agent for dyeing keratin containing fibers
AU2002212116A AU2002212116A1 (en) 2000-08-02 2001-07-26 Agent for dyeing keratin containing fibers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000138029 DE10038029A1 (en) 2000-08-02 2000-08-02 Agent for dyeing keratinous fibers
DE10038029.8 2000-08-02

Publications (2)

Publication Number Publication Date
WO2002009662A2 true WO2002009662A2 (en) 2002-02-07
WO2002009662A3 WO2002009662A3 (en) 2002-06-27

Family

ID=7651298

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/008656 WO2002009662A2 (en) 2000-08-02 2001-07-26 Agent for dyeing keratin containing fibers

Country Status (4)

Country Link
EP (1) EP1304995A2 (en)
AU (1) AU2002212116A1 (en)
DE (1) DE10038029A1 (en)
WO (1) WO2002009662A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8444713B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a naphthalen-1-ol and derivatives thereof
US8444714B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-Hexy1/Hepty1-4,5-diaminopyrazole and a benzene-1,3-diol and derivatives thereof
US8444711B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzene-1,3-diamine and derivatives thereof
US8444709B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a 2-aminophenol and derivatives thereof
US8444710B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a m-aminophenol and derivatives thereof
US8444712B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzo[1,3]dioxol-5-ylamine and derivatives thereof
US8460397B2 (en) 2011-02-22 2013-06-11 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a pyridine and derivatives thereof
US8784505B2 (en) 2012-02-16 2014-07-22 The Procter & Gamble Company 1-hexzl-1H-pyrazole-4,5-diamine hemisulfate, and its use in dyeing compositions
US8785656B2 (en) 2012-02-16 2014-07-22 The Procter & Gamble Company Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt
WO2014138979A1 (en) * 2013-03-13 2014-09-18 Canadian Blood Services Pyrazole derivatives and their uses thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238212B2 (en) 2003-06-02 2007-07-03 L'oreal, S.A. Imidazole compounds and use of these compounds for dyeing keratinous fibers
FR2855406B1 (en) * 2003-06-02 2006-08-04 Oreal NOVEL IMIDAZOLE COMPOUNDS AND THE USE THEREOF FOR THE DYING OF KERATIN FIBERS

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061289A (en) * 1988-12-24 1991-10-29 Wella Aktiengesellschaft Oxidation hair dye composition containinng diaminopyrazol derivatives and new diaminopyrazol derivatives
DE4234885A1 (en) * 1992-10-16 1994-04-21 Wella Ag Process for the preparation of 4,5-diaminopyrazole derivatives, their use for dyeing hair and new pyrazole derivatives
US5430159A (en) * 1992-10-16 1995-07-04 Wella Aktiengesellschaft N-phenylaminopyrazole derivatives as well as composition and process for the dyeing of hair
EP0740931A1 (en) * 1995-05-05 1996-11-06 L'oreal Compositions for dyeing keratinic fibers containing diaminopyrazoles, process for dyeing, diaminopyrazoles and process for their preparation
FR2788521A1 (en) * 1999-01-19 2000-07-21 Oreal Cationic oxidation bases for use in compositions for dyeing keratin fibres such as hair dye compositions, consist of pyrazole derivatives with cationic groups containing optionally saturated quaternized rings

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061289A (en) * 1988-12-24 1991-10-29 Wella Aktiengesellschaft Oxidation hair dye composition containinng diaminopyrazol derivatives and new diaminopyrazol derivatives
DE4234885A1 (en) * 1992-10-16 1994-04-21 Wella Ag Process for the preparation of 4,5-diaminopyrazole derivatives, their use for dyeing hair and new pyrazole derivatives
US5430159A (en) * 1992-10-16 1995-07-04 Wella Aktiengesellschaft N-phenylaminopyrazole derivatives as well as composition and process for the dyeing of hair
EP0740931A1 (en) * 1995-05-05 1996-11-06 L'oreal Compositions for dyeing keratinic fibers containing diaminopyrazoles, process for dyeing, diaminopyrazoles and process for their preparation
FR2788521A1 (en) * 1999-01-19 2000-07-21 Oreal Cationic oxidation bases for use in compositions for dyeing keratin fibres such as hair dye compositions, consist of pyrazole derivatives with cationic groups containing optionally saturated quaternized rings

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8460397B2 (en) 2011-02-22 2013-06-11 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a pyridine and derivatives thereof
US8444714B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-Hexy1/Hepty1-4,5-diaminopyrazole and a benzene-1,3-diol and derivatives thereof
US8444711B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzene-1,3-diamine and derivatives thereof
US8444709B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a 2-aminophenol and derivatives thereof
US8444710B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a m-aminophenol and derivatives thereof
US8444712B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzo[1,3]dioxol-5-ylamine and derivatives thereof
US8444713B2 (en) 2011-02-22 2013-05-21 The Procter & Gamble Company Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a naphthalen-1-ol and derivatives thereof
US8784505B2 (en) 2012-02-16 2014-07-22 The Procter & Gamble Company 1-hexzl-1H-pyrazole-4,5-diamine hemisulfate, and its use in dyeing compositions
US8785656B2 (en) 2012-02-16 2014-07-22 The Procter & Gamble Company Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt
US9060953B2 (en) 2012-02-16 2015-06-23 The Procter & Gamble Company 1-hexyl-1H-pyrazole-4,5-diamine hemisulfate, and its use in dyeing compositions
WO2014138979A1 (en) * 2013-03-13 2014-09-18 Canadian Blood Services Pyrazole derivatives and their uses thereof
US10130609B2 (en) 2013-03-13 2018-11-20 University Health Network Pyrazole derivatives and their uses thereof
US11090288B2 (en) 2013-03-13 2021-08-17 University Health Network Pyrazole derivatives and their uses thereof

Also Published As

Publication number Publication date
DE10038029A1 (en) 2002-02-14
EP1304995A2 (en) 2003-05-02
WO2002009662A3 (en) 2002-06-27
AU2002212116A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
EP0966449B1 (en) 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes
EP1244421B1 (en) Dye combination comprising a 4,5-diaminopyrazole derivative and a chlorinated m-aminophenol
WO2002009662A2 (en) Agent for dyeing keratin containing fibers
EP1233744B1 (en) Colouring agent for keratin containing fibres
DE10144226A1 (en) New polyoxaalkyl-bridged p-phenylenediamines and salts, used as developer in oxidation color for hair or other keratinous fibers, are prepared by reacting 1-fluoro-4-nitrobenzene with polyoxaalkyldiamine and hydrogenation
EP1037592B2 (en) New developer combinations for oxidation colouring agents
EP1803438B1 (en) Developer-coupler combination
WO1999031054A2 (en) Novel p-aminophenol derivatives and the use thereof
EP1210060B1 (en) Developer-coupler combinations
WO1999065891A1 (en) Novel 2,4-diaminophenol derivatives and the use thereof
EP0873987B1 (en) Prefluoroacylated 3-Aminophenol derivatives and their use as hair dyeing agents
EP1218344B1 (en) Oxidation colorant starting products
EP1185234B1 (en) New coupling components for oxidation hair colorants
EP0979064B1 (en) Oxidation colorants
DE19826456A1 (en) Novel 3,4-diaminophenol derivatives and their use
EP1229891A1 (en) Agent for colouring keratin containing fibres
DE19746249A1 (en) Disubstituted 3-aminophenol(s) useful as coupler in oxidation colorant for keratin fibers
WO1999066889A1 (en) New coupling components for oxidation hair colouring products
DE19746250A1 (en) 2-Alkenyl-1-naphthols use as coupler in oxidation color for hair and other keratin fibers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2001980217

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001980217

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP